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Abstract

BIOLOGICAL ACTIVITY AND CONFORMATIONAL ANALYSIS OF
NIKKOMYCINS AND THEIR ANALOGS.
by
Eduardo Krainer
Adviser: Professor Fred Naider

Nikkomycins and polyoxins are peptidyl nucleoside
antibiotics produced by S t r e p t o m y c e s species. They are
potent inhibitors of chitin synthetases from pathogenic
fungi, and polyoxins have been used in Japan for many years
as agricultural fungicides and for insect control. Since
chitin synthetase is not found in mammals and both families
of antibiotics are not toxic, these inhibitors are
potentially attractive for clinical use. Unfortunately
these compounds seem to have only a fungistatic action, and
they are not used clinically at present.

A procedure for efficiently obtaining nikkomycins X
and Z of very high purity from crude antibiotic is
described. These nikkomycins are very intractable to
separation by conventional chromatography. Our protocol
relies on the use of reversed-phase HPLC with a reactive
mobile phase (aqueous sodium bisulfite). A polar bisulfite
addition product is formed with nikkomycin X, but not

V

nikkomycin Z, within the column bed. This drastically
changes the mobility of the former antibiotic and leads to
the full resolution of both compounds. The bisulfite
addition compound can be easily reverted to nikkomycin X.
Recovery yields are in the order of 65-80 %.

Five tripeptide analogs (1-5, Table 7) and four
dipeptide analogs (9-12, Table

8

) of polyoxins and

nikkomycins with expected enhanced toxicity toward C,
albicans

were synthesized, and their biological properties

tested against various strains of this yeast. The
dipeptides were designed as double-targeted drugs, able to
inhibit chitin synthetase and/or release a toxic amino acid
upon hydrolysis. One of the tripeptides,

L-leucyl-

nikkomycin X (3), behaved as a prodrug, releasing a toxic
peptide upon intracellular hydrolysis. None of the
synthetic antibiotics proved more toxic than nikkomycin.

The conformation of nikkomycin X in aqueous solution
was examined by using nuclear Overhauser effects as well as
by pH titration studies in which ^ - n m r shifts were
monitored. The antibiotic exhibits a very flexible
structure, with coexisting s y n and a n t i conformations of
the nucleoside moiety. Conformational shifts of the pentose
ring, and also along the C 4 /-C5/bond, occurred during the
titration. The studies in aqueous solution were undertaken

as a preamble to studies of the antibiotic bound to chitin
synthetase and perhaps to peptide permeases of c.

albicans.

NOe measurements were carried out on nikkomycin X in the
presence of fungal membranes containing active enzymes, in
an effort to obtain preliminary conformational information
for the bound molecule.
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Chapter I: The introduction starts with a review of the
current knowledge of the chemical structure of the
cell-wall of C a n d i d a a l b i c a n s . Chitin synthesis is
discussed as a target for antifungal drugs. The known
natural inhibitors of chitin synthetase, polyoxins and
nikkomycins, are presented and their mechanism of action,
as well as their limitations, are discussed. The current
knowledge of the peptide transport system of C. a l b i c a n s is
discussed in some detail, since it is utilized by the
chitin synthetase inhibitors for permeation into the cell.
Finally, data from the literature as well as our own
observations on the stability of the nikkomycins under
hydrolytic conditions is examined.

Chapter II: The introduction to this chapter is a brief
discussion on the methods in the literature for the
purification and separation of the nikkomycins. It is
shown how a mixture of nikkomycins X + Z was isolated from
crude antibiotic by reversed-phase HPLC. Attempts at
resolving this mixture are discussed, and the concepts
behind chemochromatography are presented.
'Chemochromatography: its use for the separation of
nikkomycins X and Z' describes the development of this
novel mode of reversed-phase HPLC and its success in the

xii

analytical and preparative separation of nikkomycins X and
Z. This work was published in A n a l y t i c a l

Biochemistry,

1987, with R. K. Khare, Fred Naider, and Jeffrey M. Becker.

Chapter III; The introduction to this chapter is a review
of the polyoxin analogs that have been reported in the
literature. This review is separated into two sections,
dipeptide analogs and tripeptide analogs, in order to make
the presentation more clear. The effects of different
chemical modifications on the toxicity of the analogs
against c. a l b i c a n s are discussed. When there is no data
available, the toxicity against phytopathogenic fungi is
presented instead.

'Synthesis and biological evaluation of

dipeptidyl and tripeptidyl polyoxin and nikkomycin analogs
as anticandidal prodrugs' was submitted in a modified
version to J o u r n a l

of M e d i c i n a l

Chemistry

in 1990, with

Fred Naider and Jeffrey M. Becker, and was accepted for
publication. This work tries to extend previous concepts
and introduces novel approaches to the problem of
anticandidal drug design. Finally, the appendix presents
data showing nikkomycin to be resistant to hydrolysis by
peptidases from C. a l b i c a n s .

Chapter IV: In the first section, the problems and
advantages of different approaches for obtaining

1 H-nmr

spectra of nikkomycin X in aqueous solution are discussed,

xiii

and the results of preliminary experiments are shown. The
second section,

'Conformational studies of nikkomycin X in

aqueous solution' is a work published in B i o p o l y m e r s in
April 1990 with Fred Naider and Jeffrey M. Becker. In it,
the conformational behavior of nikkomycin X in solution is
explored. Appendix B expands the conformational studies of
the ribose ring from the previous section, presenting data
used in the calculations, as well as drawings of the
conformers. The next section introduces the concept of
transferred nuclear Overhauser effect; finally, in the last
section, preliminary results of nmr studies on nikkomycin
in the presence of active enzymes from c. a l b i c a n s
membranes are presented.

Note: The references are grouped at the end of the last
section, last Chapter. Sections that have also been
submitted or published elsewhere have an independent system
of references.
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Chapter I. Introduction and background.

Chitin synthesis and peptide transport in C a n d i d a a l b i c a n s .

Candida

albicans

is an imperfect dimorphic yeast

usually associated with warm-blooded animals as a harmless
and asymptomatic commensal. In immunologically weakened
hosts, however, C. a l b i c a n s can manifest itself as a
virulent pathogen. Despite its being the most common and
most serious fungal pathogen of man, many important aspects
of its biology are still not understood (1 ).

The cell-wall of C. a l b i c a n s , as that of
Saccharomyces

cerevisiae,

is composed mainly of p-glucans,

mannoproteins, chitin and lipids (2,3). The main structural
component of the c.

albicans

wall is p-glucan (48-60%)

containing I->3 and l -»6 linkages (3,4). Mannoprotein
(20-23%)(3) is distributed throughout the cell-wall but
also accumulates on the surface and next to the plasma
membrane (1). p-(l-»6 ) Glucan may be cross-linked to
mannoprotein (5). Chitin (1-3 %)(3) is located mainly in
the bud scar in c. a l b i c a n s yeast cells, but smaller
amounts are distributed throughout the inner wall (6,7).
Chitin, a linear polysaccharide composed of p-(l-»4)-linked
N-acetylglucosamine units, is an essential component for
maintenance of the structural stability of the cell-wall

2

and for the formation of primary septa in budding cells
(8 ). The N-H and C=0 groups in adjacent chains of chitin
associate by hydrogen bonding. The very strong association
between chains accounts for the formation of fibrils, as
well as for the insolubility of chitin in water (9, 10).
Covalent linkages between chitin and glucans have only been
investigated recently (1 ,

11

glycosidic bond at position
position

1

), and there is evidence for a
6

of N-acetylglucosamine and

of the glucose in the p-(l-»6 )-glucan.

Chitin synthetase, the enzyme responsible for the
last step in chitin biosynthesis, is located predominantly
in the plasma membrane (12). Its substrate, UDP-GlcNAc,
approaches the membrane from the cytoplasmic face and
transfers the GlcNAc through the synthetase to a chain of
chitin which, as it grows, is simultaneously

extruded (9).

No energy source other than that provided by the free
energy of hydrolysis of the bond between the amino sugar
and UDP appears to be necessary (9). Chitin synthetase is
present in the cell as a zymogen and can be activated in
vitro

by proteolysis. Chitin synthetase from s.

cerevisiae

has been isolated in its active form by co-precipitation
with its product, chitin (13). Interestingly, the chain
length of chitins synthesized in v i v o , with a membrane
preparation, or with the purified enzyme, is the same in
all cases (somewhat more than 100 GlcNAc units). This

3

suggests that chitin synthetase itself is capable of
determining the length of the chitin chains (13)'.

Chitinase is a soluble enzyme that shows maximum
activity during c. a l b i c a n s yeast growth (14). It is
probably required for localized hydrolysis of wall chitin
and for the softening of walls which appears to be
necessary for growth (9).

It has been found recently (15, 16, 17) that there are
two chitin synthetase activities in S. c e r e v i s i a e . Chitin
synthetase I, which is not essential for cell growth and
seems to be just a repair or auxiliary enzyme, is the main
in v i t r o measurable activity. Chitin synthetase II, on the
other hand, is essential for synthesis of chitin and septum
formation. Very recently (18), evidence was also presented
for the existence of at least two chitin synthetases in C.
albicans.

A gene coding for one of the chitin synthetases

in C. a l b i c a n s

(chitin synthetase I, a protein of 776 amino

acids) was cloned by expression in S. c e r e v i s i a e . This
candidal gene is homologous (37% amino acid identity) to
the gene coding for chitin synthetase I in s.

cerevisiae.

It is not known whether chitin synthetase I in c, a l b i c a n s
is also non-essential for growth.

Chitin synthetase is a potential target for clinically

HO
NH\

HO
HO

HO

OH

Uridine diphosphate N-acetyl glucosamine

HN
OH

NH
CO„H

2

N

HO

OH

Polyoxin D

0
HN
NH

OH

•NH...

CH

HO

OH

HO
Nikkomycin Z

Figure 1

Substrate and inhibitors of chitin
synthetase.
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important antifungal drugs, since the structural
polysaccharide chitin is not present in mammalian cells.
The most effective known inhibitors of fungal chitin
synthetase, polyoxins (19) and nikkomycins (20)

(Figure 1),

are not used clinically at present. It has been shown,
however, that a mixture of nikkomycins X and Z (see Table 2
for structures) is effective in prolonging the survival
time of mice experimentally infected with C. a l b i c a n s

(21),

but these antibiotics seem to have just a fungistatic
action. This behavior correlates with the existence of
large discrepancies (2-3 orders of magnitude) between
reported MIC values for inhibition of fungal growth and Ki
values for the inhibition of chitin synthetase in v i t r o .
This discrepancy is due to the failure of the nikkomycins
and polyoxins to reach their target within the cell.
Translocation of these antibiotics into the cell takes
place through peptide permeases (22,23). All polyoxins and
nikkomycins have at least one peptide bond, and the
membrane transport system of c.

albicans

recognizes these

antibiotics as peptides (23). The cause of the failure of
these inhibitors to accumulate intracellularly appears to
be a low rate of permeation, and not their putative
metabolism by the yeast (see below and Chapter III).

Peptide uptake in C.

a l b i c a n s takes place through an

active peptide transport mechanism, with passage of the
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intact peptide across the cell membrane. The possibility of
hydrolysis in the membrane, with vectorial transport,
cannot be ruled out in some strains of c. a l b i c a n s

(24). In

general, separate amino acid and peptide transport systems
seem to exist, but the evidence for this is not conclusive
and the question will probably remain open until genetic
studies of peptide transport are undertaken (24).
Independent dipeptide and oligopeptide permeases have been
suggested to be present in c.

albicans

WD 18-4 (25), but

this point is not very clear (24). A common transport
system has been proposed for the uptake of both di- and
tripeptides by c. a l b i c a n s 6406 (26), and two distinct
transport systems, one accepting both di- and tripeptides
and the second more specific for trimethionine, were
postulated in the case of C. a l b i c a n s ATCC 26278

(27).

Although it is possible that different C. a l b i c a n s strains
may possess different peptide transport systems, evidence
to date seems to support the presence of a general system
which recognizes di- and tripeptides (and perhaps also
tetrapeptides). A second system (or more than one) does not
have an appreciable affinity for most dipeptides (24).

Knowledge of the side chain specificity of the
different peptide permeases can be exploited in the design
of anticandidal drugs. At present, there is not enough data
to discuss the specificity of individual transport systems

7

in c. a l b i c a n s . It is generally accepted that peptides
containing lysine are not well transported into this yeast,
whereas hydrophobic peptides are excellent substrates for
the permeases (24)

(nevertheless see Chapter III). On the

other hand, a-N-acylated peptides are usually transported
into C. a l b i c a n s , whereas peptide esters are not (24). A
dipeptide with a

d

residue at either the amine or carboxyl

terminus is non transportable, but the situation with
oligopeptides is less clear (24). It appears that some
tripeptides containing

d

residues, such as

d-Met-l-Met-l-Met (25), or Arg-D-X-Phe where X is an amino
acid (28), are transported. The

d

residue cannot be located

at the carboxyl terminus. On the other hand, at present, no
peptide with more than one d-residue is known to be
recognized by the transport system of c. a l b i c a n s

(24). The

above information was incorporated into the design of
modified polyoxins and nikkomycins with improved
permeability (see Chapter III).

8

Polyoxins.

The polyoxins are a family of peptidyl nucleoside
antibiotics produced by S t r e p t o m y c e s c a c a o i .

Their

structures (see Table 1) were elucidated in the sixties by
Isono's group (19). The unusual amino acids found in these
compounds have the

l

configuration and are, from the amino

terminus:
a)S-Carbamoyl polyoxamic acid,
OH

NH,
I

0

OH

( 3 S , 4S)-5-[(aminocarbonyl)oxy]-3,4-dihydroxy-L-norvaline,
or in the case of polyoxin G, carbamoyl deoxypolyoxamic
acid, where the hydroxyl group at the p position is absent,
b) Polyoxin C, or
0

HO

OH

1- (5'-amino-5'-deoxy-p-D-allofuranosyluronic
acid)-5-hydroxymethyluracil. The hydroxymethyl group in
position 5 of the uracil ring can be replaced by a carboxyl

9

or a methyl group, or by an hydrogen atom (see Table 1).
c) Polyoximic acid,
C0oH

NH
CH.3
(25)-3-ethylideneazetidine-2-carboxylic acid, has an
ethylidene group which is t r a n s with respect to the
carboxyl group. The a H y l i c character of the a hydrogen
accounts for the facile racemization of this compound when
it is obtained by acidic hydrolysis of polyoxins (19).

Polyoxins D, E, and F have been converted (29) to
polyoxins L, M, and K respectively, by decarboxylation of
the 5-carboxyuracil moiety. This reaction was carried out
in two steps: first, the nucleophilic addition of sodium
bisulfite to the 5,6-double bond accompanied by
decarboxylation, and then elimination of the sulfonate
group by alkali.

Some of the constituent amino acids of the polyoxins
have already been synthesized. The synthesis of carbamoyl
polyoxamic acid is described in (30), and the synthesis of
polyoxin c-type amino acids in (31-33). The preparation of
a precursor of polyoximic acid is described in (34).
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06

OH

D

c o 2h

OH

OH

E

c o 2h

OH

H

F

c o 2h

G

c o 2h

H

CH,3

OH

0
h 2n

J

ch 3

K

H

OH
CO,H
0^

- r

CO-H
oS

H
OH
OH
OH

L

H

CO.H
OH

M

H

OH

OH
H

0
>L
HN

/

COR 2 JL

II
2o ^ > '

H K'.. '

C

cCH,OH
h 2o h

1

cCH
h 22o0H
h

OH
.
j

biologically
inactive

Ny ~ J^

biologically
inactive

1

1

c o 2h

HO

OH

Table 1

Polyoxins (19, 29).

Polyoxins are structurally similar to uridine
diphosphate N-acetyl glucosamine (Figure 1), the substrate
of chitin synthetase. They are competitive inhibitors of
this enzyme, the inhibition constant Ki being remarkably
constant for chitin synthetases from different sources. Ki
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values are in the 10"6-10"7 M range (9). Polyoxins enter c.
albicans

through a peptide transport system (35, 23). Thus,

di- and tripeptides present in the growth media antagonize
the anti - C a n d i d a activity of polyoxins. Furthermore,
polyoxin-resistant mutants of C. a l b i c a n s exhibit
cross-resistance to bacilysin and other toxic di- and
tripeptides (23).

The free carboxyl group at C-5', as well as the free
(positively charged) amino group are required for chitin
synthetase inhibition (36-38). Thus acylation or alkylation
of the C 2" - a m i n o group, as well as amidation of the
carboxyl group, results in inactive or poor enzyme
inhibitors (38-40). Further aspects of the effects of
chemically modifying the polyoxins will be examined in
Chapter III.
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Nikkomycins.

Nikkomycins are peptidyl nucleoside antibiotics
structurally related to polyoxins (Table 2). Like the
polyoxins, they are potent competitive inhibitors of chitin
synthetase and use the peptide transport system for entry
into yeast cells (41, 42). Their isolation from
fermentation broths of S t r e p t o m y c e s

tendae,

as well as

their chemical structures have been described in the late
seventies by a German group (20, 43-46). In 1980 Isono's
group reported the detailed structures of a new family of
antibiotics which they called neopolyoxins A, B, and C
(47-49). The neopolyoxins were produced by s t r e p t o m y c e s
cacaoi

subsp. a s o e n s i s . These antibiotics turned out to be

identical to nikkomycin X, an oxidized form of nikkomycin
X, and nikkomycin Z, respectively. Despite some initial
confusion about whether or not there were stereochemical
differences between the constituent amino acids of the
nikkomycins and the neopolyoxins (48, 49), it is now clear
that these antibiotics are identical (50). Neopolyoxins A
and C will be referred to as nikkomycins X and Z.

The amino acids present in the nikkomycins have the
configuration, are biologically inactive in their free
form, and are, from the amino terminus:

l
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:omycin

X

B

CHCO
CCHO
Bx
CHCO
Z
zT
C (CH.)CO
C(CH,OH)CO
ZH
X
CCHO
J
CHCO
JT
C (CH-)CO
C(CH,OH)CO
JH
I
CCHO
CHCO
KZ
CCHO
KX
CHCO
°z
CCHO
°x
CHCO
Qz
CCHO
Qx
idyoxin B c h c o 2h
CCHO
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CHCO
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HO

HOi
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OH
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N
M
C
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HO
OH

D
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2

W
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—2

—3

CH
CH
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
CH
CH

CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
N
N

OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
H
H
OH
OH
OH
OH
OH
H
H

CH.
ch3
CH,
CH,
CH,
CH,
CH '
CH,
CH,
ch 3
H
H
H
H
CH,
ch 3
CH,
CH,
ch 3

OH
OH
OH
OH
OH
OH
Glu
Glu
Glu
OH
OH
OH
OH
OH
Hse
Hse
OH
OH
Glu

CHCO
CCHO
CHCO
CCHO

Cx

OH

Y

Glu
Glu
OH
OH
N
N

CH
CH

OH CH.
H CH.

CO.H

Table 2

Nikkomycins (47, 51-54).

a) nikkomycin D,

HO"

v

'3

(25,35,45)-2-amino-4-hydroxy-4-(5-hydroxy-2-pyridyl)-3-
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-methyl butyric acid, or variations in which the phenolic
hydroxyl group or the methyl group are missing, or the
nitrogen atom in the pyridine ring is in a different
position or absent (see Table 2).
b)

Nikkomycin C, 1-(5'-amino-5'-deoxy-p-D-

-allofuranosyluronic acid)uracil,
o

HO
OH
and nikkomycin C x, 1-(5'-amino-5#-deoxy-p-D-allofuranosyluronic acid)4-formyl-4-imidazoline-2-one

HO

OH

It has been shown that in the biosynthesis of the
polyoxins the pyrimidine nucleoside moiety is formed by
condensation of uridine and phosphoenol pyruvate (55, 56).
It is very likely that the nucleoside moiety of nikkomycin
C is formed from uridine and that a subsequent ring
contraction of the uracil to the imidazolinone ring then
takes place (49). This kind of rearrangement has been
previously described (57), and was used for the conversion
of nikkomycin C into nikkomycin C x (49).
c)

Glutamic acid or homoserine are present as carboxy

terminal amino acids in some of the nikkomycins (see Table
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2).

The synthesis of the N-terminal amino acid of the
nikkomycins has been carried out by different groups. A
non-stereoselective synthesis of the N-terminal amino acid
of nikkomycin B, where the key step is a 1,3-dipolar
cycloaddition, is described in (44). Further refinements of
this synthesis leading to nikkomycin D are described in
( 5 8 ) . Two stereoselective syntheses of the N-terminal amino

acid of nikkomycin B have been achieved, one by Banks e t
al.

(59),

and another by Melnick e t

al.

(60),

who used an

intramolecular [4 + 2]-cycloaddition reaction.

An important point to be considered when studying the
biology of these antibiotics, or when one has to manipulate
them, i.e. for purification, is their stability toward
chemical and enzymatic hydrolysis. The peptide bond in
polyoxin D is resistant to hydrolysis by peptidases from c.

a l b i c a n s (61). There is no previous report, to our
knowledge, on the stability of nikkomycins toward
degradation by fungal peptidases. This latter point will be
further addressed in Chapter III. Nikkomycins X and Z are
fairly stable in aqueous solution at below neutral pH, but
are rapidly degraded under alkaline conditions. Nikkomycins
K x and 0 X, in comparison, have been shown to be stable at
pH 7 and 8

( 5 2 ) . It has been proposed that anchimeric
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assistance is the reason for the unusual instability of
nikkomycins in aqueous solution (48):
.CO.H
uracil

NHMe'
HO

OH

OH

Data from the literature on the hydrolysis of
nikkomycins, as well as our own results, are summarized in
Table 3. Only dipeptide nikkomycins are considered. The
reported products of hydrolysis are also shown.
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Extent or

Conditions
Time

Solvent
X +

z

TFA IN

100°C

Products

1 hr nik D
nik C+Cx
nik X+Z

Z (?)

HC1 6N
HC1 12N
TFA IN

110°C 20 hr nik D, 1,
2, uracil
37°C 48 hr
100°C

1 hr nik D+C

pH 3-45-6-7\20°C
8-9.
1 mg/mL /

Yield (%) Comments

Ref

isolated
isolated
isolated

20

42
29
14

43

100
partial
partial

0

biol.
test

43

Bx

TFA IN

100°C

1 hr nik Cx ,3,
4, 5.

44

X

NaOH HN 100°C

1 hr nik D+Cx ,
base

49

leucine-\
aminonik D
pepti )37°C 6 day
nik Cx
dase.
pH 6.4 /

55
39

isolated
isolated

1 hr nik D
uracil

16
17

isolated
isolated

z

NaOH HN 100°C

X

pH 5.5

20°C 8 day
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HPLC

pH 7.0

20°C 4.7daj

50

HPLC

pH 8.0

20°C 4.6day

50

HPLC

pH 5.5

20°C 30 day

47

HPLC

pH 7.0

20°C 30 day

35

HPLC

pH 8.0

20°C 30 day

15

HPLC

Kx

Table 3

Hydrolysis of nikkomycins (dipeptides).
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Conditions
iUM»vuiyuiu

Extent or

xcrnp •

pH 5.5

20°C 30 day

17

HPLC

pH 7.0

20°C 30 day

50

HPLC

pH 8.0

20°C 30 day

55

HPLC

X

pH 7.23

37°C 44 hr

50

HPLC

this work

z

pH 7.23

37°C 44 hr

50

HPLC

this work

3.7

HPLC

this work

°x

X +

z

TFA .05% 60°C 2.2hr

Table 3

(continued).
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Chapter II. Purification of nikkomycins X and Z.

Introduction.

Crude nikkomycin was obtained as a gift from Bayer
Pflanzenschutz Leverkusen. This material contained a
mixture of nikkomycins X and Z ( ~ 48%) and small amounts
of other nikkomycins, as well as extraneous materials
(salts, pigments, etc.). The purification of the crude
material using reversed-phase HPLC (high-performance liquid
chromatography) was attempted, in order to obtain 100 mg
amounts of nikkomycins X and Z for biological and chemical
work.

The original purification of nikkomycins X and Z by H.
Hagenmaier et a l ., and specifically the separation of these
two major antibiotic components of S t r e p t o m y c e s
fermentation broths, employed derivatization with dimedone
and column chromatography on cellulose, as well as
treatment with an alkylamine resin and further purification
by HPLC using an RP-8 column (20). These methods sacrifice
one component to obtain the other, and the reported yields
are extremely low.

Another approach for the separation of nikkomycins
(62, 63) has utilized reversed-phase HPLC with a RP-8
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column, eluting with a combination of step and linear
gradients

with 30 mM ammonium formate buffer (pH 3.75) and

1 mM heptanesulfonic acid in water and in methanol. The
heptane sulfonic acid acts as a lipophilic counter-ion.
This was used as a quantitation method of nikkomycins in
fermentation broths. Although nikkomycins X and Z are
separated from other components, it would not be practical
to scale up these conditions for the preparative
purification of the nikkomycins because the counter-ion,
heptanesulfonic acid, would be difficult to remove.
Furthermore, baseline separation between nikkomycins X and
Z was not achieved and the little resolution of these
antibiotics would be lost in the scale-up. It is
interesting that the authors (63) stated that
chromatographic separation of nikkomycins that differ only
in the nucleobase is difficult, almost impossible.

Purification of nikkomycins.

Reversed-phase packings, as well as the use of
lipophilic ion-pairing reagents, have been increasingly
popular for the analytical and preparative HPLC of peptides
(64-68). The reversed-phase packings consist of silica gel
to which a hydrocarbon, usually a chain of 4, 8 or 18
carbon atoms, has been chemically attached. Partitioning of
the solute occurs between the hydrophobic stationary phase
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and a polar aqueous mobile phase. Being able to use aqueous
solvents is very advantageous in processing polar
non-solvent extractable compounds. Trifluoroacetic acid is
widely used as an anionic ion-pairing reagent in the
reversed-phase HPLC of peptides because its low boiling
point allows for easy removal during freeze-drying.
Furthermore, C i 8 reversed-phase chromatography using
trifluoroacetic acid / water as the mobile phase has been
successfully applied to the purification of natural and
synthetic polyoxins (69, 70).

Attempts to purify the nikkomycins from the crude
fermentation product using a TFA 0.05% mobile phase and a
pBondapak C i 8 (Waters) stationary phase resulted in
isolation of a mixture of nikkomycins X and Z. Figure 2
shows analytical chromatograms at different concentrations
of TFA. The major peak corresponds to the mixture of
nikkomycins X and Z. The resolution of these components
could not be increased by varying the concentration of TFA
(from 0 to 0.10% ). Although the higher concentrations led
to increased retention and marginal resolution (not seen in
the figure), the high acidity is detrimental to the column
(69). The increase in retention times appears to be due to
ion pairing with protonated amino groups, as well as to an
ion suppression effect on the carboxylic acid (65, 71)

. A

similar chromatographic behavior, namely a sharp decrease
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Figure 2

Analytical chromatogram of crude nikkomycin, with
various amounts of TFA in the eluant. Support: pBondapak C18 (30cmx3.9mm) (Waters). Flow rate:
1.40 mL/min. X :254 nm. Retention times in minutes.
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of retention times with the addition of small amounts of
TFA and then increased retention as more TFA is added, has
been described for small unrelated peptides (65).

257 mg of pure nikkomycins X + Z were recovered from
500 mg of crude antibiotic when the conditions shown in
Figure 2, at 0.05% TFA, were scaled-up for preparative
work. The 1H-nmr spectrum of this mixture is shown in
Figure 3. The mixture is 75:25 nikkomycin X / nikkomycin Z,
as estimated from the relative areas of peaks such as the
ones at 6 7.72 (s, H-5, nik X), 9.24 (s, CHO, nik X) and
5.68 (d, H-5, nik Z), 7.46 (d,

H-6, nik Z) .

Since nikkomycin X has an aldehyde group, it should

in

principle be possible to form a derivative which could be
separated from nikkomycin Z and then reversed to nikkomycin
X. Sodium bisulfite has been used extensively for the
separation of carbonyl compounds from other materials and
was the obvious reagent choice. However it should be noted
that nikkomycins are non-extractable water-soluble
materials, and a bisulfite derivative of nikkomycin X would
also be water soluble and more polar.

First attempts at resolving the nikkomycin X + Z
mixture consisted of dissolving it in a saturated solution
of NaHS03 in H 20 and injecting onto the reversed-phase C 18

^*»"|iy<» 11 " ^ V i^ V

..I.
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L^jUu

i

u

u. J-.

10

to

Figure 3

200 MHz 1H-nmr spectrum of nikkomycin X + Z in DMSO-dg.
Tip angle: 30°;Relaxation delay: 4 sec;Reference: internal TMS.
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column, with H 20/TFA as eluant. Interestingly, three
different peaks could be clearly distinguished in the
resulting chromatogram (see Figure 4). The first large
peak, coming with the solvent front, is NaHS03. The second
peak, with retention time of 3.52 min

is presumably the

nikkomycin X bisulfite addition compound. Some at first
sight odd or unexpected features of this chromatogram are
immediately apparent: a) the baseline between the second
and third peak is somewhat above the rest of the baseline
and has a positive slope, and b) the third peak, which
would on first thought correspond to nikkomycin Z, the
minor component (25%), is actually much larger than the
second peak. This can be explained by noting that the
bisulfite addition compound is in equilibrium with the free
aldehyde,
OH

0

and its decomposition, catalyzed by the acid present in the
eluant, occurs in the column as the run proceeds. Thus, the
third peak contains some nikkomycin X, and the elevation of
the baseline observed between the second and the third peak
is caused by nikkomycin X, which is formed gradually and
migrates at a slower rate than the addition compound.

The rate at which the chemical reaction occurs in the
column has to have a large impact in the appearance of the
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Figure 4

Analytical chromatogram of nikkomycin X + Z dis
solved in aqueous NaHS03. Eluant: TFA 0.005%.
Support: p-Bondapak C18 (30cmx3.9mm) (Waters).
Flow rate: 1.40 mL/min. A :254 nm. Retention times
in minutes.
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final chromatogram. If the rate of decomposition of the
bisulfite addition compound were very slow as compared to
the rate at which the solutes move in the column, good
separation would be achieved: the third peak would only
consist of nikkomycin Z, and the baseline between the
second and third peak would be flat. Conversely, one can
imagine that if the rate of decomposition were very fast,
the second peak (RT = 3.52 min) would completely disappear
and the third peak would consist of the original mixture of
nikkomycins X and Z. The actual chromatogram seen (Figure
4) corresponds to an intermediate case, where the rates of
reaction and of migration are comparable.

In actuality the rate of formation of the bisulfite
adduct under conditions compatible with the chromatographic
run is much faster than the rate of decomposition; taking
advantage of this, the separation of the two nikkomycins
can be achieved. This will be shown in the manuscript which
follows.
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Chemochromatoaraphv: its use for the separation of
nikkomycins X and Z.
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Chemochromatography: Its Use for the Separation of Nikkomycins X and Z 1
Eduardo Krainer, R. K. Khare, Fred Naider, and Jeffrey M. Becker*
Department o f Chemistry. College o f Staten Island. Staten Island, New York 10301, a n d *Department o f
Microbiology, University o f Tennessee, Knoxville, Tennessee 37996
Received July 14,1986
A novel mode o f reversed-phase high-performance liquid chromatography in which the
mobile phase reacts chemically with the compounds to be separated was developed. Nikkomycin X and nikkomycin Z, two natural isomeric nucleoside peptide antibiotics, move as a single
peak on a C , 8 reversed-phase column using an aqueous trifluoroacetic acid mobile phase.
Addition o f sodium bisulfite (1.0%) to the mobile phase results in the formation o f a polar
bisulfite addition product with nikkomycin X, but not with nikkomycin Z, inside the HPLC
column. This type of reactive chromatography, or chemochromatography, led to the analytical
and preparative separation o f nikkomycins X and Z which are normally very intractable to
separation by conventional chromatographic techniques, o 1987 A cadem ic Press, inc.
K e y W o r d s : chemochromatography; nikkomycin; nucleoside peptide antibiotics; reversedphase HPLC techniques; NMR.

Nikkomycins, nucleoside peptide antibi
otics produced by Streptomyces tendae, have
potential value as therapeutic agents and
pesticides (1-6). As a result o f the structural
resemblance o f the nikkomycins to uridine
diphosphate-A'-acetylglucosamine, the natu
ral substrate o f chitin synthetase, these anti
biotics are potent inhibitors o f this enzyme
in both fungi and arthropods (7-10).
Previous attempts to separate nikkomycin
X (1) and nikkomycin Z (2) (two major bio
logically active components o f Streptomyces
fermentation broths) (Fig. 1) have utilized
column chromatography on cellulose (3) and
reversed-phase chromatography on an RP-8
column (9,11). In all cases it was extremely
difficult to separate 1 from 2 without sacrific
ing one o f the components. Some resolution
o f nikkomycins X and Z was obtained using
analytical HPLC (3,11), but these conditions

1 This work was supported by grants from the Na
tional Institute o f Allergy and Infectious Diseases
(A M 4387 and AI-42631) and the PSC-BHE Awards
Program o f CUNY.

Reprinted by permission of
the publisher

could not be scaled up for the preparative
separation o f these antibiotics since baseline
separation was not achieved and the coun
terion, heptanesulfonic acid, would prove
difficult to rem ove. Indeed investigators
stated that separation o f nikkomycins which
differ only in the nucleobase is difficult, al
most impossible (9). With trifluoroacetic
acid as the ion-pairing agent, we found that 1
and 2 moved as a single unresolved peak.
The chromatographic modes which use a
chemical reaction to selectively influence the
mobility o f the sample, and which we call
collectively chemochromatography, tradi
tionally use a reactive stationary phase. Such
is the case for the AgNOj-impregnated silica
gel plates for olefinic samples, or the borateimpregnated silica gel for complexing glycol
compounds (12). To separate 1 and 2 we de
cided to use a reactive mobile phase. Specifi
cally, we used an additive in the m obile
phase o f our reversed-phase HPLC system
which would react with 1 (an aldehyde) but
not with 2, reasoning that mobility changes
accompanying such a reaction might make
the separation possible.
0003-2697/87 $3.00
Copyright C 1987 by A cadem ic Press, Isc .
All rights o r reproduction in any form reserved.
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OH
HO
NH— CH

OH OH

X

SOjN

1.R =

•— OH

HN

HO
F ig . 1. Structure o f nikkomycins. Compounds 1, 2, and 3 are nikkomycin X , nikkomycin Z, and the
bisulfite addition compound of nikkomycin X, respectively.

The desirable characteristics for this reac
tion “in the column” are: (i) The reaction
should be quantitative or nearly quantita
tive. (ii) Its rate has to be very fast as com
pared to the rate at which the compounds of
interest move in the column so that the reac
tion is complete in the very first portion o f
the column bed. (iii) The chromatographic
mobility o f the derivative formed has to be
different from the mobility o f the unreacted
compound, (iv) From a preparative point o f
view, the reaction should be reversible, so
that the original material can be recovered
easily.
In this communication we report the suc
cessful analytical and preparative separation
o f 1 and 2 using chemochromatography. Our
procedure employs sodium bisulfite as the
component o f the mobile phase which rap
idly reacts with 1 forming a derivative with
modified chromatographic properties.
MATERIALS AND METHODS
A Waters Associates (Milford, MA) HPLC
system consisting o f an M-45 solvent deliv
ery unit, a U6K universal liquid chromato
graph injector, a Waters Lambda-Max
Model 481 spectrometer, and a Waters
M730 data module was used for analytical
separations. All separations were accom 
plished using a jtBondapak C )8 colum n
(Waters) (particle size, 10 /mi; length, 30 cm;
internal diameter, 3.9 mm).
Preparative separations were carried out

on a Waters Prep LC/system 500 instrument
equipped with a refractive index detector. Ei
ther a Waters One-Inch Semiprep column (1
in. x 1 ft) packed with Waters preparative
C|g-column packing material (particle size,
55—105 urn) or a Waters Prep PAK-500/C|8
cartridge (80-#tm mean particle size, 30 X 5.7
cm) was used for purifications.
TFA2 (Aldrich, Milwaukee, WI) was o f re
agent grade and was used without purifica
tion. The sodium bisulfite used (Fisher Sci
entific Co., Fair Lawn, NJ) is a mixture of
sodium bisulfite (NaH SO j) and sodium
me/a-bisulfite (Na2S20 5) (assay as S 0 2 not
less than 58.5%). The solutions were pre
pared with glass-distilled water, filtered (Millipore, 0.45 nm), and deaerated under vac
uum before acidification. All concentration
percentages are expressed as weight per vol
ume. Activated carbon (Aldrich) used for de
salting was o f nucleotide desalting grade and
was slurry-packed after degassing the slurry
under vacuum. Crude nikkomycin (~48% 1
+ 2) was obtained from Bayer Pflanzenschutz Leverkusen.
'H NMR spectra at 200 MHz were ob
tained on a Brucker spectrometer and were
run at 25°C. Reported chemical shifts are
relative to TMS or DSS3 as internal refer2 Abbreviations used: TFA, trifluoroacetic acid; TMS.
tetramethylsilane; DSS, sodium 3-(trimethylsilyl)-l-propanesulfonate; RT, retention time; MIC, minimum in
hibitory concentration.
3 Used for samples run in D 2Q.
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ences. Optical rotations were determined on
a Perkin-Elmer Model 141 polarimeter. For
elem ental analyses, freeze-dried sam ples
were further dried under vacuum over P20$
at 65 °C, for 44 h. Elemental analyses were
performed by Galbraith Laboratories, Knox
ville, Tennessee.
Purification o f nikkomycin. In order to ob
tain a mixture o f pure 1 and 2 from commer
cial nikkomycin, 500 mg o f crude antibiotic
was dissolved in 15 ml o f aqueous TFA
(0.25%), injected onto the Prepak-500/Ci8
preparative column, and eluted with TFA
(0.05%). Fractions were monitored using an
alytical HPLC (Fig. 2). The fractions con
taining the peak at RT 8.15 min were pooled
and freeze-dried. A TFA salt (257 mg) was
obtained in this way. ‘H NM R analysis
showed this material to be a 75:25 mixture o f
1 and 2. Specifically in DMSO-tfk 1 exhibited
singlets at 7.72 ppm (H-5) and 9.24 ppm
(CHO) whereas 2 exhibited doublets at 5.68
and 7.46 ppm for H-5 and H-6, respectively.
The relative areas under these resonances
were used to estimate the content o f isomers
1 and 2.

Fig . 2. Analytical chromatogram o f crude nikkomy
cin, using a fiBondapak C ia support. The eluant is
C F 3C O 2H (0.05%), the flow rate was set to 1.40 ml
m in '1, and the detector was adjusted in the absorbance
units mode at 254 nm. Retention times are in minutes.

Fig. 3. (a) Analytical and (b) preparative chemochromatograms for a 1 + 2 mixture, using a Cu reversedphase support. The eluant is water containing NaHSOj
( 1.0%) and CF 3CO 2 H (0.005%). In (a) the flow rate was
set to 1.40 ml min * 1 and the detector was adjusted in the
absorbance units mode at 290 nm. In (b) the flow rate
was 50 ml min ' 1 and 50 mg of nikkomycin were in
jected. Detection o f refractive indexes relative to the sol
vent. Retention times are in minutes.

Pure nikkomycin X and Z were recovered
by dissolving 50 mg o f the mixture o f 1 and 2
in 1.5 ml o f distilled water and injecting it
onto the 1-in. C,8 reversed-phase column,
using a freshly prepared solution o f N aH S03
(1.0%) and TFA (0.005%) (w/v) in water as
the eluant. The column was previously equil
ibrated with the same mobile phase. Figure 3
shows both the analytical and the preparative
chromatograms.
The fractions corresponding to 2 (peak
with RT 7.52 min, Fig. 3a, and RT 9.7 min,
Fig. 3b) were pooled and immediately de
salted by percolating the solution through a
column o f activated carbon. Approximately
1 ml bed/mg o f nikkomycin Z was used. The
colum n was washed with water until no
N aH S 03 was present in the effluent. An at
tem pt to recover 2 by eluting with acetone:water (40:60) was unsuccessful, but,
after rewashing the colum n with water, 2
could be eluted with methanol:water:concentrated ammonium hydroxide (80:20:0.1).
After concentration and freeze-drying 6.2 mg
o f 2 was obtained.
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NM R.
0.78 (3H , d, J = 7.1 Hz,
Me-3"), 2.72 (1H , m, H-3"), 4 .2 -4 .6
(H-2',3',4',5',2"), 5.13 (1H, d, J = 2.9 Hz,
H-4"), 5.86 (1H, d, J = 5.2 Hz, H-l'), 5.87
(1H , d, / = 8.0 H z, H -5), 7.45 (2H , m,
H-3"',4"'), 7.69 (1H, d, J = 8.0 Hz, H-6), 8.08
(1H, broad, H-6").
Elemental analysis. Found: C, 41.54; H,
5.36; N, 12.30%. Calculated for C2oH25O ioN j-4 .5 H20 : C, 41.67; H, 5.94; N , 12.15%
W d c = +25.0 (c 0.1, H20 )
The fractions corresponding to the bisul
fite addition compound o f nikkomycin X (3)
(large peak with RT 3.65 min, Fig. 3a, and
RT 4.7 min, Fig. 3b) were pooled, acidified
with dilute HC1 to pH 2.5, degassed under
vacuum, reacidified, and concentrated under
vacuum, maintaining the pH constant at 2.5
with dilute HC1. In order to regenerate free 1
from 3 the solution was diluted and concen
trated several times under vacuum at pH 2.5.
Alternatively 1 could be recovered from 3 by
bubbling nitrogen through the solution for a
few hours, while keeping the pH at 2.5. This
transformation was followed by HPLC (TFA
(0.10%) as the eluant) and stopped when
complete. The concentrated solution was fi
nally desalted by injection in the 1-in. C |8
reversed-phase column, using TFA (0.10%)
in H20 as the eluant. Pure nikkomycin X
(29.5 mg) was obtained after concentration
and freeze-drying.
NMR. C 150-* 0.60 (3H, d, J = 7.0 Hz,
Me-3"), 2.57 (1H, m, H-3") 3 .9 -4 .4
(H-2',3',4',2"), 4.65 (1H, dd, H-5'), 4.95 (1H,
d, J = 2.7 Hz, H-4"), 5 .4 8 (1H, d, J = 5 .0 Hz,
H -l'), 7.31 (1H, dd, J = 8.5 and 2.2 Hz,
H-4"'), 7.36 (1H, d, J = 8.5 Hz, H-3"'), 7.72
(1H, s, H-5), 8.09 (1H, dd, J = 2.2 and 0.8
Hz, H-6"'), 8.0-8.2 (3H, NHJ), 9.13 (1H, d, J
= 7.8 Hz, CONH), 9.24 (1H, s, CHO), 10.2
(broad, ArOH), 11.22 (1H, s, NH-3).
Elemental analysis. Found: C, 36.87; H,
3.72; N, 8.85; F, 14.71%. Calculated for
C20H2jO 10N 5 -2 T F A .3 H 2O: C, 37.07; H,
4.28; N, 9.01; F, 14.66%. [a&5#c = +16.0 (c
0.1, H20 ).

RESULTS AND DISCUSSION
Trifluoroacetic acid has been shown to be
a very useful anionic ion-pairing reagent in
the reversed-phase HPLC o f peptides
(13-15). The increase in retention times ob
served at low concentrations o f TFA in water
is apparently due to ion-pairing with protonated amino groups and/or to an ion suppres
sion effect in the carboxylic acid functionali
ties (13,16). The low boiling point o f TFA
allows its easy removal during freeze-drying.
Attempts to purify 1 and 2 from a crude
fermentation product using a trifluoroacetic
acid 0.05% mobile phase resulted in isolation
o f a mixture o f these antibiotics. As seen in
Fig. 2 ,1 and 2 move as an asymmetric unre
solved peak, RT 8.15 min. The resolution o f
these components could not be further in
creased by varying the trifluoroacetic acid
concentration (0-0.10% , w /v). Although
higher concentrations o f the acid (0.10%) led
to increased retention on the column and
some additional resolution (data not shown),
this concentration o f acid slowly deactivated
the reversed-phase column. Sodium bisulfite
is also not stable in high concentrations o f
acid. A minimum retention time (4.28 min)
was observed at a trifluoroacetic acid con
centration o f approximately 0.01%; below
this concentration the mobility o f the peptidyl-nucleoside antibiotics decreases and in
pure water 1 and 2 move as an unresolved
peak which tails badly. The trifluoroacetic
acid concentration used for further separa
tions was chosen to maximize the retention
time o f the antibiotics without destroying ei
ther the column or the sodium bisulfite. For
this purpose the concentration region be
tween 0 and 0.01% trifluoroacetic acid was
most appropriate and 0.005% acid worked
very well.
Separation o f 1 from 2 was carried out by
reversed-phase chromatography in the pres
ence o f sodium bisulfite. The analytical and
preparative chemochromatograms for the 1
+ 2 mixture are shown in Fig. 3. After a
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F ig. A. Partial FT 'H NMR spectrum o f nikkomycin X at 200 MHz. (a) In D 20 . (b) With sodium
bisulfite added ( 1.0%). Shifts from DSS (internal reference) in ppm.

negative peak at the origin, due to water, the
peaks o f interest appear. As expected from its
polarity, the bisulfite addition compound 3
has a very low RT (3.65 min) and can be
easily separated from 2 (RT 7.52 min). The
preparative chem ochrom atogram corre
sponds to 50 mg o f mixture and shows base
line separation between the peaks corre
sponding to 3 and 2 (Fig. 3b). The reaction of
N aH S 03 with 1 has the four characteristics
mentioned in the introduction. Reinjection
o f purified 1 in this chromatographic system
showed that the conversion o f 1 to 3 is quan
titative, since a single peak was observed at
RT 3.65 min. Furthermore, no trace o f 1 was
observed in isolated 2.
Figure 4a shows the partial 'H NMR spec
trum o f purified 1 in D20 . When sodium
bisulfite is added (1.0%), the result repre
sented in Fig. 4b is obtained. Conversion o f 1
to 3 in the NMR tube is indicated by loss o f
the aldehyde proton signal at 9.30 ppm (Fig.

4b) and the appearance o f a new singlet at
5.35 ppm that corresponds to -C //O D SO J.4
The singlet at 7.70 ppm in Fig. 4a, corre
sponding to H-5 (1), is strongly shifted up
held in Fig. 4b (6.75 ppm) due to its proxim
ity to the sulfonate moiety. These NM R re
sults show that the aldehyde group in
nikkomycin X is rapidly and quantitatively
converted to an addition compound under
conditions simulating those in the chroma
tography column.
After reversal o f the addition compound 3
using the procedure described under Mate
rials and Methods, nikkomycin X was de
salted on a C |8 reversed-phase column. In
this manner we were able to recover 29.5 mg

4 The resonances o f aldehyde protons in sodium bi
sulfite addition compounds fall in the range 4.5-5.0 ppm
for aliphatic aldehydes listed in (17). For the bisulfite
addition product o f benzaldehyde, that resonance is at
5.SI ppm (in DjO) (unpublished results).
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o f pure nikkomycin X. This represents a 78%
yield assuming that 1 is present as the double
trifluoroacetic acid salt in the mixture ( 1 + 2 )
as it is in purified 1.
In contrast to the desalting o f nikkomycin
X which was carried out on a C 18 column, a
different approach was taken to desalt nik
komycin Z. This change was necessitated by
our observation that N aH S03 reacts slowly
with nikkomycin Z under the conditions
used to concentrate the HPLC fractions prior
to desalting. We believe that the bisulfite
adds to the double bond o f the uracil ring. A
similar reaction o f bisulfite with a pyrimidyl
double bond was previously observed during
conversion o f polyoxin D to polyoxin L (18).
Although we could desalt 2 by degassing the
concentrated solution at low pH, raising the
pH with NaOH, and injecting onto a re
versed-phase HPLC column, it proved more
convenient to desalt using activated carbon.
The total recovery o f nikkomycin Z was 6.2
mg, which represents a 67% yield if one takes
into account that the hydrated free peptide is
obtained, and assuming a 3H20 • 2TFA form
in the starting material, as in the case o f nik
komycin X. Significant losses were taken
during the desalting step and are probably
due to irreversible adsorption to the acti
vated carbon column. N o attempt was made
to optimize this step.
Inhibition o f chitin synthetase was assayed
for isolated 1 and 2 using a mixed membrane
fraction from C andida albicans H - 3 17
(19,20). For nikkomycin X an IDj05 value of
0.1 Mg/ml was obtained and for nikkomycin
Z the IDso value was 0.24 Mg/ml. Under vir
tually identical conditions polyoxin D was 4to 10-fold less active (20). The MIC6 foT nik
komycin X was determined to be ~ 4 pg/ml
when tested with C. albicans 124. These re

5 The concentration or compound that inhibited by
50% the activity o f chitin synthetase as measured by the
incorporation of A'-acetylglucosamine into chitin.
6 The lowest concentration o f antibiotic that clearly
inhibits growth.
I■

suits are comparable to findings reported in
the literature using other test organisms. Spe
cifically using chitin synthetase from Cop r im s cinereus nikkomycin was a 2- to 6fold more effective inhibitor than polyoxin D
(7). Using strain C. albicans 124, McCarthy
el al. (21) report an MIC o f 25 Mg/ml for a
mixture o f nikkomycins X and Z (80% pure).
C. albicans Tii 164 yielded an MIC o f 1
Mg/ml when tested against nikkomycin X
(22). Given the known dependence o f MIC
values on media and laboratory protocol all
o f these findings are in reasonable agree
ment.
CONCLUSION
The methods described herein allow the
rapid and efficient separation o f nikkomycin
X and nikkomycin Z. In addition to the pre
parative potential o f the procedure it is obvi
ous that chemochromatography with a reac
tive mobile phase is an excellent procedure
for the analysis o f mixtures o f these com
pounds. The extension o f this approach to
other isomeric molecules differing in their
functional groups should add a significant
tool to the arsenal o f the chromatographer.
REFERENCES
1. D ahn. U .. Hagenmaier, H., Hohne, H., Konig.
W. A.. Wolf. G., and Zfihner. H. (1976) Arch.
Microbiol. 107,143-160.
2. D ahn, U ., Hagenmaier, H., H ohne, H., Konig.
W. A., Scheinpflug. H.. and Zahner, H„ U.S. Pa
tent 4.046,881, Sept. 6 . 1977.
3. Hagenmaier. H., Keckeisen, A., Zahner, H., and
K onig, W. A. (1 9 7 9 ) Liebigs Ann. Chem..
1494-1502.
4. Kdnig, W. A., Hass, W„ Dehler, W„ Fiedler, H. P..
and Zahner, H. (1980) Liebigs Ann. Chem.,
622-628.
5. Konig. W. A., Pfaff. K. P., Bartsch, H., Schmalle.
H., and Hagenmaier, H. (1980) Liebigs Ann.
Chem., 1728-1735.
6 . Hagenmaier. H„ Keckeisen, A., Dehler, W„ Fiedler.
H. P., Zahner, H „ and Konig, W. A. (1 9 8 1 )l/> bigs Ann. Chem. 1018-1024.
7. Brillinger, G . U . (1979) Arch. Microbiol. 121,
71-74.

35
CHEMOCHROMATOGRAPHY OF NIKKOMYCINS X AND Z

8.

Miiller. H., Furter, R., Zahner. H., and Rast, D. M.
i M l ) A r c h . Microbiol. 130, 195-197.

9. Fiedler. H. P., Kurth, R., LanghSrig, J.. Delzer, J.,
and Zahner, H. (1982) J. Chem. Technol. Biolechnol. 32 ,2 7 1 -2 8 0 .
10. Yadan, J. C., Gonneau, M., Sarthou. P., and Le
Goffic. F. (1984) J. Bacleriol. 160,884-888.
11. Fiedler, H . P. (1981) J. Chromatogr. 204,313-318.
12. Lindsay, J„ and Morris. L. (1964) Lab. Pract. 13,
284-286.
13. Shenbagamurthi. P., Naider, F., Becker, J. M.. and
Steinfeld. A. S. (1983) J. C hrom atogr. 256,
117-125.
14. Schaaper, W. M. M.. Voskamp, D., and Olieman.
C. (1980) J. Chromatogr. 195, 181-186.
15. Harding, D. R. K„ Bishop. C. A., Tarttelin. M. F„
and Hancock, W. S. (1981) Int. J. Pept. Protein
Res. 18,214-220.

16. Bidlingmeyer, B. A. (1980) J. Chromatogr. Sci. 18,
525-539.
17. Pouchert, Ch. J. (1983) The Aldrich Library o f
NM R Spectra, Vol. 2, pp. 7 9 6 -7 9 7 , Aldrich
Chemical Co., Milwaukee, WI.
18. Shibuya, K., Tanaka, M., Nanbata, T., Isono, K..
and Suzuki S. (1972) Agric. Biol. Chem. 36,
1229-1236.
19. Naider. F.. Shenbagamurthi, P., Steinfeld, A. S.,
Smith, H. A., Boney, C„and Becker, J. M. (1983)
Antimicrob. Agents Chemother. 2 4 ,787-796.
20. Shenbagamurthi, P.. Smith, H. A., Becker, J. M.,
Steinfeld. A. S., and Naider, F. (1983) J. Med.
Chem. 26, 1518-1522.
21. McCarthy. P. J., Troke, P. F„ and Gull, K. (1985) J.
Gen. Microbiol 131, 775-780.
22. Bormann, C., Huhn. W., Zahner, H., Rathmann,
R., Hahn, H., and Konig, W. A. (1985) J. Antibiot. 38, 9-16.

36

Chapter III. Nikkomycin and polyoxin analogs.

Dipeptide polyoxin analogs.

In 1971 Isono et a l . prepared dipeptide analogs of
polyoxins and tested their toxicity against some
phytopathogenic fungi (72, 73). Representative results for
these and further experiments carried out by other
investigators (see below) are shown in Table 4. The
compounds at entries 2 and 3, showed a toxicity comparable
to that of Polyoxin J (entry 1), indicating that the
hydroxyl groups in the carbamoyl polyoxamic acid are not
necessary for activity. The studies of these investigators
also showed that compounds containing a second amino group
in the amine terminal residue (entries 9 and 10, Table 4),
as well as compounds where this residue has the

d

configuration (entries 8 and 12), have very weak or no
toxicity.

In 1974 Hori et al. took these studies one step
further and assayed the dipeptide analogues as inhibitors
of a chitin synthetase preparation from P i r i c u l a r i a o r y z a e
(74). They assessed the partial binding affinities to
chitin synthetase of different atomic groups or moieties of
the polyoxin molecule. Their results complement the
findings by Isono. The investigators showed that the change

R,-HH
HO
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231
65
6
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13
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16
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7

8

11109
12

s,

Conpound or Residue
Polyoxin J

MIC*

OH

l -CH(OH)CH(OH)CHjOCONHj
ol -CH,CHjCH jOCOSHj
L-CHjCHjCHjNHCOHH,
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of configuration at position
from

l

to

d

,

position from

a

of the amino acyl residue

as well as the shift of the amino group
a

to 0, reduces considerably the binding to

the enzyme. Interestingly, they found a high inhibitory
activity for phenylalanyl polyoxin C, a compound that Isono
et a l .

(73) showed to be non-toxic (Table 4, entry 14).

These results indicate that this analog does not reach its
target enzyme within the cytoplasm:

itis either unable

permeate efficiently the cell wall,

or is rapidly degraded

(by peptidases)

to

inside the cell.

The authors also demonstrated that the amino group at

c -2 ' '

is crucial for binding to the enzyme (74).

Furthermore, they showed that in order to have effective
inhibition, the pH of the medium has to be such that the
amino group at C - 2 "

is protonated (75).

It had been shown (76) that dipeptides antagonize the
inhibitory action of polyoxins against phytopatogenic
fungi. In 1983, studies from this laboratory demonstrated
that polyoxin D greatly affects the

morphology of the

zoopathogenic yeast C. a l b i c a n s and

is fungicidal at

millimolar concentrations. It was proposed that transport
of polyoxin into c.

albicans

is mediated by peptide

permeases (22). In 1984, Mehta et a l . showed this to be
indeed the case (23).
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Thus, logical evaluation of polyoxin analDgs should
include not only the usual toxicity studies, but also
assays of chitin synthesis inhibition and transport into
the cell. Furthermore, since the antibiotics can be
degraded by peptidases in the cytoplasm before reaching
their target enzyme, stability in the presence of cell
extracts should also be evaluated (70).

Shenbagamurthi et a2. prepared a series of polyoxin L
analogs specifically designed as anticandidal agents (Table
4, entries 18 to 23 )(70). These compounds were good chitin
synthetase inhibitors, but high doses were necessary in
order to inhibit c. a l b i c a n s growth. This was shown to be
due to poor transport and/or degradation to inactive
products by intracellular enzymes. If polyoxins could be
chemically modified, in such a way that they would
penetrate C. a l b i c a n s , resist enzymatic degradation, and
inhibit chitin synthetase, efficient killing of this yeast
would result. Novel dipeptide chitin synthetase inhibitors
resistant to intracellular degradation were prepared in
this laboratory (70, 78)

(Table 4, entries 27 to 31). The

resistance to enzymatic hydrolysis was achieved by
utilizing a D-amino acid (entry 29), or by N-alkylation of
the terminal amine (entries 27 and 28). Resistance to
peptidases also resulted from incorporation into the
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polyoxin of an amino acid with a bulky hydrophobic residue
(entries 30 and 31). An important finding was that although
the first two strategies resulted in poor chitin synthetase
inhibitors (entries 27 to 29), the hydrophobic polyoxins
(entries 30 and 31) were excellent inhibitors of this
enzyme. Nevertheless, these latter two antibiotics did not
seem to utilize the peptide transport system to reach the
cytoplasm and were non-toxic (78) .

Recently, hydrolysis resistant and transportable
inhibitors were prepared in this laboratory (79)(i.e. entry
36, Table 4). The MIC values were perhaps higher than one
would expect, and probably not low enough for clinical
applications. It should be pointed out that extreme care
has to be exercised when interpreting the biological
assays. In particular, the transport competition results
might very well be reflecting affinity of the inhibitor but
not translocation into the cytoplasm. It has been shown,
for instance, that nikkomycin has a high K m for the peptide
permeases but its V m is much lower (~5%) than that of
dimethionine (27). Further limitations of the biological
assays will be discussed later.

Table 5 lists other dipeptide polyoxin analogs found
in the literature, with structural modifications such as a
N-methyl group at the amide (entry 2), or a

d

configuration

I
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OH
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H
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L
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at C-5'(entries 3 and 4). The mentioned compounds were
intended to be hydrolysis resistant (80). Analogues with a
p-amino group, or a a-aminooxy group (entries 6 and 8) have
also been prepared (70, 74). None of these analogues proved
to be a good chitin synthetase inhibitor.

Trineotide nolvoxin analogs.

Hoping to obtain analogs with greater permeability,
Isono's group prepared some tripeptidyl polyoxins (Table 6,
entries 1 to 7) along with the dipeptides mentioned above
(73). Inclusion of an adamantoyl group in the 6-amino group
of an amine-terminal ornithine (entry 6) resulted in a
considerable decrease of activity. The toxicity of the
other tripeptides toward P. oryzae was not significantly
higher than that of Polyoxin J (Table 4, entry 1), the best
drug being Leucyl-Polyoxin L (Table 6, entry 4).

Naider et a l .

(81) synthesized tripeptidyl polyoxins

(Table 6, entries 8 to 10), some of which behaved as
prodrugs. Although none of these compounds were chitin
synthetase inhibitors, Leu-Polyoxin D and Leu-Nle-UPOC
(entries 8 and 9) were shown to deliver toxic species
(Polyoxin D and Nle-UPOC respectively) after hydrolysis
inside C. a l b i c a n s . Nle-UPOC was hydrolyzed further, to Nle
and UPOC, both inactive species, a fact that greatly

Chitin

MIC3

Inhibition
Compound

1
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3
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5

6
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Hydro Transport
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50
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25
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>100
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40
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2
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+
+
-
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11
59
7
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no
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81
81
69
69
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diminished the efficacy of the drug.

Other tripeptidyl polyoxins prepared in this
laboratory (70)

(entries 11 and 12) inhibited chitin

synthetase to some extent, a fact that was unexpected.
These compounds are the first known tripeptide inhibitors
of chitin synthetase. They resisted degradation and had low
toxicity against c. albicans.

New tripeptidyl polyoxins and nikkomycins, designed to
be degraded by peptidases at specific bonds, will be
examined in the next section. Dipeptide analogs designed as
double targeted drugs will also be considered.
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Synthesis and biological evaluation of dipeptidvl and
tripeptidyl polvoxin and nikkomycin analogs as anticandidal
prodruas.
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ABSTRACT

Nine analogs (1-5, 9-12) of the peptidyl nucleoside
antibiotics nikkomycin and polyoxin were synthesized and
tested for their biological properties against different
strains of the pathogenic yeast Candida albicans. The
tripeptidyl series of analogs (1-5) was designed to behave
as prodrugs, releasing a toxic moiety upon enzymatic
hydrolysis inside the cell. The dipeptidyl series (9-12)
was designed as double-targeted drugs, being themselves
toxic and releasing a toxic amino acid upon hydrolysis.
All the analogs were prepared by coupling suitably
protected aminoacid p-nitrophenyl esters to
1-(5'-amino-5'-deoxy-a-D-allofuranosyluronic acid) uracil
(UPOC) or the corresponding polyoxins and nikkomycins, with
subsequent removal of the protecting group. Improved
coupling yields were observed when DMSO was used as the
solvent. Products were purified using reversed-phase HPLC
and, in one case, diastereomeric products (compound 11)
were resolved using this procedure. One of, the tripeptidyl
nikkomycins behaved as a prodrug but none of the compounds,
as measured by in vitro testing, proved more effective than
nikkomycin as an anticandidal agent.
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INTRODUCTION

Opportunistic infections by Candida albicans are major
contributors to patient morbidity and mortality in
immunocompromised hosts1,2. This has become particularly
significant in recent years with increased use of
immunosuppressive therapies and with the emergence of
acquired immunodeficiency syndrome. Since the drugs
currently in use for the treatment of candidiasis suffer
from significant clinical limitations, a clear need exists
for the development of effective anti-candidal drugs.

Polyoxins and nikkomycins are closely related
families of peptidyl nucleoside antibiotics produced by
species of Streptomyces. These compounds are toxic to
phytopathogenic fungi3'5 and, to a lesser degree, to some
zoopathogenic fungi such as Candida a l b i c a n s 6 '7 . The
intracellular target for both families of antibiotics is
chitin synthetase. This inner membrane enzyme catalyzes the
synthesis of chitin, a polysaccharide of
N-acetylglucosamine and an important structural component
of fungal cell walls.

Since no similar macromolecular

constituent is present in mammalian cells, chitin
synthetase is an obvious target for an anticandidal agent.

The polyoxins and nikkomycins are potent competitive
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inhibitors of c. albicans chitin synthetase. Values of I D 50
for nikkomycins X or Z fall in the 0.1 - 0.2 ug/mL range8
when enzyme inhibition is measured in a membrane
preparation from disrupted c. albicans cells. The MIC
values, however, are significantly higher (e 10 ug/mL for
the nikkomycins, see below) when measuring the effect of
the inhibitors on growth of C. albicans in culture. These
findings could be the result of the failure of these
antibiotics to accumulate intracellularly or to their
metabolism by the yeast. Degradation inside the cell does
not seem to be the problem, since polyoxins have been shown
to resist Candida peptidases9, and nikkomycins, on the
basis of their structural relation to polyoxins, would be
expected to behave similarly in that respect. In contrast,
polyoxin and nikkomycin permeation into the cell takes
place through peptide permeases and this is the step that
appears to be rate limiting in the case of C. a l b i c a n s 7 , 1 0 .

We have prepared polyoxins that are very good
competitors against dileucine uptake in C. albicans,
indicating high affinity for the dipeptide transport
system11 yet these compounds were not effective in the
inhibition of cell growth. It is possible, however, that
even antibiotics with high affinity for the peptide
transport system are not efficiently translocated into c.
a l b i c a n s . Nikkomycin Z has been shown to have the same K m
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for transport as dimethionine but the V m was only five
percent of that of the dipeptide10. Furthermore,
a-aminolauryl UPOC, a synthetic polyoxin analog recently
prepared by u s 11 is an excellent chitin synthetase
inhibitor, is stable to intracellular degradation and has
high affinity for the dipeptide transport system. However,
it fails to kill C. albicans possibly because it is not
translocated efficiently into the yeast.

Some strains of c.

albicans handle peptides through at

least two distinct transport systems with different
selectivities for dipeptides and tripeptides7,10. It is
possible that the efficacy of the polyoxins and nikkomycins
might be increased if these dipeptidyl nucleosides could
also enter C. albicans through the tripeptide transport
system. In addition even if nikkomycin or polyoxin were
degraded inside the yeast, killing would still result if at
least one of the degradation products remained toxic. To
explore the above strategies, we have prepared a number of
tripeptidyl nikkomycins and polyoxins using amino acid
residues expected to improve recognition by the tripeptide
transport system (Table 7). These tripeptides should not be
inhibitors of chitin synthetase but should be hydrolyzed to
toxic dipeptides. Thus they are putative prodrugs. We have
also synthesized a variety of polyoxin analogs containing a
known antimetabolite (Table 8, 10-12). These multi-targeted
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drugs have the potential to inhibit chitin synthetase and
release the toxic amino acids oxalysine12,
meta-fluorophenylalanine13 and N 3-(4-methoxyfumaroyl)-

l-

2 , 3-diaminopropanoic acid

(FMDP)14. In this

communication we report the synthesis of novel polyoxin and
nikkomycin analogs and the evaluation of their
intracellular stability, transportability, inhibition of
chitin synthetase, and anticandidal activity.

CHEMISTRY

1-(5'-amino-5'-deoxy-a-d-allofuranosyluronic acid)
uracil, which we have previously designated UPOC (uracil
polyoxin C)), is the carboxyterminus amino acid of the
synthetic dipeptides 9, 10, 11, 12, and of tripeptides 1
and 2. It was synthesized from uridine, according to
Damodaran e t al15. All analogs were prepared by coupling
suitably protected amino acid p-nitrophenyl esters with
UPOC or with polyoxins and nikkomycins (compounds 6 to 9)
and removing the protecting group. Compound 9 has
previously been synthesized in our laboratory16. In the
former report, Z-e-(oct)Lys-ONp was coupled to UPOC in
DMF/H20, in the presence of NMM.

The overall yield

(coupling and deprotection) was only 29%. This was
attributed to the low solubility of UPOC in DMF. Normally,
this can be improved by addition of water but in this case
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the amount of water had to be kept low to avoid
precipitation of Z-(oct)Lys-ONp. Dramatic improvement in
yield and product purity was attained by systematically
varying the solvent, base and catalyst (HOBt). Optimal
conditions found for preparation of 9 were DMSO as solvent,
DIEA as base, and no catalyst. Indeed, the addition of HOBt
did not result in any improvement and complicated
purification of the product. The overall yield of coupling
and deprotection was 72%, based on UPOC.

Since the solubility properties of the dipeptides were .
better, DMF/H20 was used as the coupling solvent for
preparing all tripeptides. We noticed that the yield of the
coupling reaction varied significantly from batch to batch
for (oct)Lys-(oct)Lys-UPOC (2.). The decreases in yield were
consistently accompanied by the appearance of an impurity
during the coupling reaction. The impurity was detected
during the monitoring of the reaction by TLC, had an Rf
slightly higher than the starting unprotected amino acid or
dipeptide, and was visible under UV light but did not give
a positive reaction with ninhydrin, indicating that a free
amine was not present. Small amounts of this impurity were
isolated during the purification of 2, and NMR analysis
showed it to be the N-formylated dipeptide. This
formylation was correlated to the presence of variable
amounts of formic acid in the starting dipeptide. Formate
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salts can be formed during precipitation of the products of
catalytic transfer hydrogenation where formic acid is the
hydrogen donor. NMR analysis showed that 9 exists at least
partially as a formate salt. This kind of chain terminating
side reaction has been described for couplings with active
esters of amino components present as acetate salts, and
would involve the formation of mixed anhydride
intermediates17,18. The side reaction was not detected
during the synthesis of the other tripeptides (1, 3, 4, 5)
where the starting dipeptides were previously purified by
HPLC and were present as trifluoroacetates. Since many
laboratories now routinely use catalytic transfer
hydrogenation with formic acid as the donor for
deprotection of peptides, it is advisable to exchange the
formate salt prior to chain extension.

Polyoxin B was purified according to 19, and its
structure confirmed by XH and 13C nmr spectroscopy. The
proton NMR of Leucyl-polyoxin B (5) in DMSO showed the
expected resonances, but the H-l' doublet as well as one of
the CONH doublets were split (see experimental section).
This was attributed to the coexistence of two stable
conformers of roughly the same populations in DMSO. This
phenomenon was not observed in any of the other tripeptides
(1 to 4), although the spectrum of one of the dipeptides
(m-F-Phe-UPOC, peak II) in DMSO-d6 showed a split CONH
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doublet, a split H-6 doublet, a broad NH-3 resonance and a
complex H-l', H-5' region.

For this latter compound the

spectrum was not simplified even when run at 5 5 °C. However
when the nmr sample was frozen, thawed, and the spectrum
run immediately at 2 5 °C the split peaks collapsed into the
expected pattern (analogous to that observed for peak I,
see experimental section).

L-4-oxalysine12 and (d,l)- m e t a - f luorophenylalanine
were protected with benzoyloxycarbonyl groups (Z) by
standard procedures20. Boc-FMDP was prepared according to
14. All three protected amino acids were activated as
p-nitrophenyl esters, coupled to UPOC and deprotected, to
yield dipeptides 10, 11 and 12. The two epimers of 11 were
separated by HPLC, and the peak with faster mobility (peak
I) identified as the

l

,

l

diastereomer on the basis of its

hydrolysis by C. albicans peptidases and inhibition of
chitin synthetase. In contrast the slow moving epimer (peak
II) was resistant to hydrolysis under the same conditions
and did not inhibit chitin synthetase (see Biological
Results).

BIOLOGICAL RESULTS AND DISCUSSION

Inhibition of Chitin Synthetase
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The synthetic polyoxins and nikkomycins fall into two
distinct categories.

As expected, none of the tripeptidyl

derivatives (1-5) were efficient inhibitors of chitin
synthetase (Table 7). The best inhibitor (5) was
approximately 25 times less active than the parent compound
(8, see Table 8). In comparison the nikkomycin derivatives
(3, 4) were^a minimum of 270 fold less active as compared
to the parent compounds 6 and 7, respectively (Table 7 and
Table 8). Of the dipeptidyl polyoxins (£, 10, 11, 12) only
9 and 11

(

(Table 8).

l

,

l

diastereomer) were reasonably good inhibitors

In the case of the oxalysine containing

polyoxin (10) the poor inhibition may be attributed to the
high hydrophilicity of the Oly residue.

In previous

investigations, semisynthetic polyoxins with charged or
polar side chains in the amine terminal residue were poor
inhibitors of chitin synthetase from C. albicans11,16 and
phytopathogenic fungi21. Based on their poor inhibition of
chitin synthetase, the tripeptidyl antibiotics are expected
to be active against C. albicans only if they are
efficiently transported into this yeast and hydrolyzed to
an active drug. Of the four synthetic dipeptidyl
derivatives, only 9 and 11 would be expected to kill the
yeast by inhibition of cell wall biosynthesis.

Competition for peptide transport

i
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The tripeptidyl nucleoside antibiotics synthesized in
this study (Table 7) were designed to be transported by
permeases able to handle tripeptides7. Once inside the
cell, they were expected to be hydrolyzed by cytoplasmic
peptidases, releasing dipeptide chitin synthetase
inhibitors. As shown in Table 7, with the exception of 2
none of the tripeptides competed with the uptake of (Leu)2*
It was unexpected that tripeptide 2 would compete well with
dipeptide uptake. Furthermore, compound 2 competed with
tripeptide transport as well. However, all other
tripeptidyl compounds (1, 2, 4, and 5) competed poorly with
the tripeptide substrate (Met)3.

These results were

surprising, because based on the structural specificity of
the tripeptide transport system in c.

albicans7

the

additional leucyl residue at the amine terminus was
predicted to result in increased affinity.

The nikkomycins,

6

and 7, have high affinity for the

dipeptide transport system (Table

8

), while polyoxin B,

(8 ), does not compete with the uptake of either (Leu) 2 nor
(Met)3. Among the synthetic dipeptides, only 9 and 10 were
reasonably well recognized by the system transporting
(Leu) 2 (Table

8

). In the case of 10 this is somewhat

unexpected given its high hydrophilicity and the low
affinity of the oligopeptide transport system of c.
albicans for lysine containing peptides7. Perhaps more

58

surprising is the lack of transport inhibition shown by

11

which is structurally very close to the nikkomycins,
although much more hydrophobic. Previous investigations had
indicated that hydrophobic peptides are better inhibitors
of peptide transport in C. albicans than are hydrophilic
peptides 7.

Hvdrolvsis bv cell extracts

The tripeptidyl polyoxins are ineffective in vitro
inhibitors but may be activated by intracellular enzymes to
generate polyoxins and nikkomycins which are effective
chitin synthetase inhibitors (Tables 7 and

8

). We found

that cell extracts from C. albicans H-317 degraded 3, 4 and
5 to leucine and the corresponding polyoxin and
nikkomycins. Degradation of 3. and 4 was faster than that
seen for norleucy1-uracil polyoxin C (Nle-UPOC ) 9 whereas
degradation of 5 was somewhat slower. Under the conditions
used for this assay, Nle-UPOC was completely hydrolyzed
after a 1 hr incubation with cell extract, 3 and 4 after
0.5 hr, and 5 after approximately 3 hr. 1 and 2 were not
degraded at all. These results, as well as the resistance
to hydrolysis by 9 and other analogs 1 6 , 1 1 suggest that the
very hydrophobic and bulky residue in the second amino acid
of

1

and

2

stabilizes both peptide bonds toward peptidase

degradation by Candida cell extract. The only synthetic
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dipeptide which was readily hydrolyzed by the cell extract
was the l,L-diastereomer of 11 (peak I)

(see Table

8

).

Both amino acid components were formed as products, as seen
by TLC. Peak II was resistant to hydrolysis, indicating
that it is the D,L diastereomer. The hydrolysis of the
dipeptide

12

proceeded very slowly, half of the peptide

being consumed in about 3 hr as monitored by HPLC.

Inhibition of growth of C. albicans

We studied the effect of peptides (1-12) and the toxic
amino acids on the growth of three strains of C. albicans
(Tables 7,

8

and 9). Two of the strains were wild type

(H-317 and 124) whereas strain 124N5 is resistant to
nikkomycin. It was necessary to determine the toxicity of
the component amino acids prior to evaluation of

1 0 -1 2

.

m-F-Phe has been found to be inactive against c. albicans
(strains B311 and 759) unless it is transported inside the
cell by peptide carriers13,22. Similar results were
observed against the strains examined in this investigation
(Table 9). Oxalysine shows some toxicity against all the
strains tested (Table 9). In contrast to the reported lack
of toxicity of FMDP when tested against c. albicans AMB 25
(MIC

2:

200 ug/mL)23, this amino acid showed high toxicity

toward the three strains tested here causing growth
inhibition at 7.8 ug/mL (Table 9).
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The dipeptide 12 showed low toxicity (Table

8

), a fact

that can be explained in terms of its failure to inhibit
chitin synthetase and its low transportability into the
cell.

On the other hand, the low toxicity of dipeptide 10,

a poor chitin synthetase inhibitor which has a much higher
affinity for the (Leu) 2 transport system, can be explained
in terms of its resistance to hydrolysis to toxic Oly if it
reaches the cytoplasm. The non-toxicity of 11 despite its
being a good chitin synthetase inhibitor and a good
substrate for peptidases, can be explained by its low
transportability into the cytoplasm.

None of the tripeptidyl polyoxins were effective
anticandidal agents (Table 7). Leu-nikkomycin X which was
the most potent synthetic analog had an MIC=83 ug/mL
against C. albicans 124. This MIC is lower than that found
for the dipeptide 9 despite the fact that the dipeptide is
a 60-fold more efficient inhibitor of chitin synthetase.
Thus it appears that 3 behaves as a prodrug. It is
transported into the pathogen and hydrolyzed to the toxic
nikkomycin X inside the cell. Its low effectiveness is
explained by its low affinity for both the di- and
oligopeptide transport systems. The low toxicity of 1 and 2
is not surprising because neither of these compounds is
hydrolyzed by cell extract peptidases and the intact
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tripeptides are poor inhibitors of chitin synthetase. In
comparison to 3, compound 5 is hydrolyzed at a slower rate
inside the cell (see above) and releases polyoxin B, which
is not as potent a chitin synthetase inhibitor as
nikkomycin X (Table

8

). Those differences explain the

limited effectiveness of 5 against the yeast.

The difference in toxicities of 3 and 4 is difficult
to explain, since their rate of transport, hydrolysis, and
inhibiting power of the released moiety is very similar.
One possible explanation is that although their extent of
affinity for the oligopeptide transport system is almost
the same, Leu-nikkomycin Z is not translocated to a
significant extent to an intracellular site. Supporting
this hypothesis are the data of Yadan et a l . 10

who showed

that in C. albicans nikkomycin and dimethionine had similar
K m values for the dipeptide transport system (4 uM and

6

uM, respectively) whereas their respective V m values were
0.15 pmoles min-1 and 3.5 pmoles min-1.

Recent findings 2 4 - 2 6

indicate that two chitin

synthetase activities are present in Saccharomyces
cerevisiae.

Chitin synthetase 1 is the major in vitro

activity measurable but is not essential for cell growth
and appears to be a repair or auxiliary enzyme. Chitin
synthetase 2 of S. cerevisiae is essential for chitin
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synthesis and septum formation. If multiple chitin
synthetases exist in C. albicans as well, then it is
possible that the in vitro activity we measure does not
accurately reflect in vivo chitin synthesis of the cell.
In this case, the correlation between growth inhibition and
enzyme activity measured may not be valid. Further studies
must be carried out to determine the number of isozymes of
chitin synthetase present in C. albicans.

CONCLUSION

This study reports the successful synthesis of novel
dipeptides and tripeptides which are analogs of polyoxins
and nikkomycins. Dipeptides containing Oly or FMDP were
resistant to Candidal peptidases and were consequently
ineffective drugs.

A polyoxin analog containing m-F-Phe

was not recognized by the peptide transport system.

One tripeptidyl nikkomycin (3) was hydrolyzed to an
active component after entering the yeast and therefore
appears to behave as a prodrug. The results show that the
structural specificity for peptide transport in c. albicans
may be much more complex than previously believed. It is
clear that additional knowledge of those molecular
interactions which are involved in the actual translocation
of a peptide into the yeast must precede the design of
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chitin synthetase inhibitors which will efficiently kill
this pathogen.

EXPERIMENTAL SECTION

High-performance liquid chromatography (HPLC,
analytical, Semipreparative) was carried out on a Waters
chromatograph (Waters Associates, Milford, MA) equipped
with two Model 510 solvent delivery units, a U 6 K injector
and a Model 481 variable wavelength UV detector, a Model
680 automated gradient controller, and a Model 730 data
module. Analytical separations were carried out on a Waters
micro-Bondapak C18 reversed-phase column (30 cm x 3.9 mm,
particle size 10 um) or an Aquapore spheri-5 RP18 column
(22 cm x 4.6 mm). The mobile phase was MeOH-H 2 0-TFA at a
flow rate of 1.4 mL/min. The absorbance of the column
eluants was recorded at 254 nm for all polyoxins. For
purification of final products two Waters C18
semipreparative columns (30 cm x 7.8 mm and 15 cm x 19 mm)
or an Aquapore RP-18 (25 cm x 10 mm) were used. TLC
analysis was carried out on silica gel 60 F 2 5 4 plates, 0.25
mm (Merck, Darmstadt).

The NMR spectra were recorded on a Bruker WP-200SY
instrument, and the chemical shift values are reported in
ppm relative to internal tetramethylsilane.

Optical
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rotations were determined on a Perkin-Elmer model 141
polarimeter. For elemental analyses, freeze-dried samples
were further dried in vacuum over P 2 0 5 at 65 °C for 48
hours. Elemental analyses were performed by Galbraith
laboratories, Knoxville, Tennessee. Nikkomycin X was
purified by chemochromatography 8 from a crude obtained from
Bayer Pflanzenschutz Leverkusen. Nikkomycin Z (Calbiochem,
San Diego, CA) was purified before use by HPLC (solvent,
TFA 0.10%; flow rate, 4.50 mL/min; 19 cm x 150 mm column; 2
mg shots).

Polyoxin B was obtained from an agricultural

fungicide preparation supplied by Kaken Chemical
(Honkomagome, Tokyo, Japan) as described in 19, where it is
referred to as peak I. UPOC (uracil polyoxin C) was
prepared according to Damodaran e t

al.15, and obtained

mainly as a zwitterion. N-a-benzyloxy-carbonyl-N-e-octanoyl-lysine-p-nitrophenyl ester was prepared as
described in 16. L-4-0xalysine was obtained as a gift from
Dr. Hong-Long Zhang, Shanghai Institute of Materia Medica,
Chinese Academy of Science, Shanghai.
N 2 -(tert-Butoxycarbonyl)-N 3 -(4-methoxyfumaroyl)- l -2,3-diaminopropanoic acid was prepared according to reference
1 4 .

( d , l )

-meta-Fluoro-phenylalanine was purchased from

Chemical Dynamics Corporation (South Plainfield, New
Jersey).

Polyoxin B (8 ^
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Polyoxin B was purified according to

19

and was HPLC

homogeneous. Its structure was confirmed by XH and 13C nmr.
The assigned proton resonances at 200 MHz in DMSO-d 6 were:
6

H 4.7 (1H, dd, H-5'), 5.3-5.7 (m, OH), 5.81 (1H, d, J = 6

HZ, H-l'), 6.53 (2H, broad s, C0NH 2 ), 7.39 (1H, s, H- 6 ),
8.0 (3H, broad, N H 3+), 9.0 (1H, d, J=8.2 Hz, CONH), 11.48
(1H, broad s, NH-3).

The presence of a H on the 5 position

is ruled out because H - 6 appears as a singlet at 7.39 ppm.
A C H 3 group on this position is also ruled out because
there is no resonance near 2 ppm corresponding to 5-CH3 . A
carboxyl group on position 5 has also been ruled out
the basis of the UV spectrum.
is C H 2 0H, as shown

19

on

The group on the 5 position

by the 50 MHz 13C proton decoupled

spectrum. This resonance appears at 57.0 ppm (in water,
C 6 D 6 external reference 8=128.0) and is assigned by
comparison to 5-hydroxymethyl uridine as a model compound
(59 ppm in H 2 0, DSS internal reference) and by the
splitting to a triplet in the off-resonance proton
decoupled spectrum. Polyoxin G, which also has an
hydroxymethyl group in position 5 but differs from polyoxin
B in that the OH group in position 3 • '
atom, was ruled out on the basis of the

is replaced by an H
1 3 C - 1H

splitting

patterns under off-resonance proton decoupling conditions.
The other resonances were:

6

55.2, 56.8 (a-CH), 69.1, 70.2,

70.4 (CH, ribose and polyoxamic acid side chain), 73.0 (CH,
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ribose), 83.3 (CH, ribose), 91.0 (CH, rlbose), 65.8
(CH 2 - 5 " ) ,

114.4 (C-5), 140.4 (C-6 ) , 152.0 (C-2) , and

159.5, 165.3, 168.3, and 172.2 (C~4, CONH, OCONH , and
C O 2H, unassigned).

N-€-(OctanovH-lvsvl-(uracil polyoxin C^

( (octlLvs-UPOCl

X91

Z-e-(C 7 H 1 5 CO)-Lys-ONp 4 (116 mg, 0.22 mmol) and UPOC
(60 mg, 0.2 mmol) were suspended in DMSO (2 m L ) .
Diisopropylethyl amine was added (35 uL, 0.2 mmol)

(pH a 7)

and the mixture stirred at room temperature for 20 hr.

(The

solution cleared up after a few hours). After acidification
with acetic acid (0.1 m L ) , the solvents were evaporated in
vacuo to dryness, the residue suspended in

1%

acetic acid,

triturated with a spatula, filtered, washed with water and
dried under vacuum. The solid was resuspended in ether,
triturated and filtered. Yield 0.108 g (80%). The product,
Z-€-(C 7H i 5 CO)-Lys-UPOC was homogeneous on silica thin
layers using n-BuOH/AcOH/H20 (4:1:2, Rf = 0.59) as eluant,
and was subjected to transfer hydrogenation using Pd black
(s30 mg) and 90% formic acid (0.3 mL) in methanol (3 m L ) .
The initial suspension clears with time and after 3 hr the
catalyst was removed by filtration through celite, the
filtrate evaporated to dryness, and the residue suspended
in ether, triturated and filtered. Yield 78 mg (72%).
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(Oct)Lys-UPOC was 97% pure as judged by HPLC, and its
mobility identical to a standard16.

Rf = 0.45

(1-butanol:acetic acid:water, 4:1:2).

N-€-fOctanovl)-lvsvl-N-e-foctanoyl)-lvsvl-UPOC (2)

9, (40 mg, 74 umol) from the previous step, and
Z-e-(C 7 H 1 5 CO)-Lys-ONp (46.8 mg, 89 umol) were dissolved in
DMF (0.7 m L ) . N-methylmorpholine (8.15 uL, 74 umol) was
added and the mixture stirred at room temperature for 15
hr. After acidification with acetic acid (0.1 m L ) , the
solvents were evaporated in vacuo to dryness. The residue
was treated with ether, filtered, washed with 4% citric
acid, water, and dried under vacuum. The product was
subjected to transfer hydrogenation as described for 9 for
1.5 hr. The catalyst was removed by filtration through
celite, the filtrate evaporated to dryness, and the residue
suspended in ether and filtered. 36.2 mg of crude
(oct)Lys-(oct)Lys-UPOC was obtained, 24 mg of which were
purified by reversed-phase HPLC using a 250 x 10 mm
semiprep Aquapore RP-18 column with 0.1% TFA/MeOH 47:53 as
eluant. 13.9 mg of pure 2 was obtained after concentration,
suspension in ether and filtration. Yield = 31%, based on
9. Rf = 0.57 (1-butanol:acetic acid:water, 4:1:2).
+8 . 8

(c=0.2, DMF). NMR. 5 H D M S 0 _ d 6

[o(]d25=

0.85 (6 H, t, J=6.2 Hz,

-CH 3 ), 1.1-1.8 (32H, m, -CH2-), 2.03 (4H, m,a-CH 2 of
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octanoyl), 3.00 (4H, m, €-CH 2 of Lys), 3.76, 4.0-4.2 (4H,
m, H-2', 3', 4 #, a-CH, unassigned), 4.35 (1H, m, a-CH),
4.50

(1H, m, a-CH), 5.26 (1H, broad, OH), 5.44 (1H, broad,

OH) 5.68 (1H, d, J=8.1 Hz, H-5), 5.79 (1H, d, J=6.4 Hz,
H - l #), 7.54 (1H, d, J= 8 .1 Hz, H- 6 ), 7.79 (2H, t, 5.8 Hz,
e-NH of Lys), 7. 8 - 8 .5 (4H, unresolved, two broad peaks at
8.05

and 8.44 ppm when run at 400 MHz, N H 3+ and CONH

respectively), 8.54 (1H, d, J=8.3 Hz, CONH), 11.38 (1H,
broad s, NH-3). Elemental Analysis. Found: C, 51.47; H,
7.33; N, 10.70%. Calculated for CasHgsOnNy

• C F 3 C 0 2H • H 20

: C, 51,77; H, 7.39; N, 10.56%.

N-g-Formvl-N-e-octanovl-lvsvl-UPOC

Small amounts (1 mg) of this formylated dipeptide were
isolated as an impurity during the HPLC purification of
tripeptide 2. R f=0.47 (1-butanol:acetic acid:water, 4:1:2).
NMR.
(16H,

6 H D M S ° - d 6 0.86

(3H, t,

m,-CH2-), 2.02 (2H, t,

J=6.1 Hz, C H 3) , 1.15-1.74
J=7.3 Hz, a-CH 2 of octanoyl),

2.99 (2H, m, e-CH 2 of Lys), 3.95-4.15 (3H, m, H-2', 3',
4'), 4.43 (1H, m, a-CH), 4.56 (1H, m, a-CH), 5.28 (1H,
broad, OH), 5.44 (1H, broad, OH), 5.64 (1H, d, J=8.3 Hz,
H-5),

5.79 (1H, d, J=6.4 Hz,H-l'), 7.45 (1H, d, J=8.3

H- 6 ),

7.75 (2H, broad t, e-NH of Lys),

Hz,

8.03 (1H, s, CH of

formyl), 8.30 (1H, d, J= 8 . 8 Hz, CONH), 8.41 (1H, broad,
CONH), 11.37 (1H, s, NH-3). FAB mass spectrometry indicated
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a molecular ion

[M + H +] at 570.2 daltons. Calculated MW:

569.6 daltons.

Leucvl-N- ( octanovl)-1vsvl-UPOC (1)

The procedure was similar to the preparation of 2,

and

was carried out using Z-Leu-ONp (51 mg, 132 umol) and 9
(72.1 mg, 110 umol) in 1 mL of DMF. 9 had been previously
purified, according to 16, and was a TFA salt. The coupling
time was 42 hr and 50 mg of Z-Leu-(oct)Lys-UPOC (Yield =
58%) was

obtained. It was homogeneous on silica thin

layers, with n-BuOH/AcOH/H20 (4:1:2, Rf=0.67) as eluant.
The deprotection took 1.5 hr, and 32.5 mg of the tripeptide
1 was obtained (overall yield = 42%) which was homogeneous
on silica thin layers, with the same eluant (Rf=0.54) and
did not need further purification. Reversed-phase HPLC
analysis (spheri-5 RP-18 column, eluant 0.1% TFA/MeOH
45:55) showed higher than 99% purity.
(c=0.09, DMF). NMR. 8HDMSO"d6
1.75

[a] D 25 = +8.9

0.86 (9H, m, -CH3) , 1.15-

(19H, m, -CH2- and CH), 2.02 (2H, t, J=7.2 Hz, a-CH 2

of octanoyl), 2.98 (2H, m, e-CH of Lys), 3.67, 4.0-4.4 (6 H,
m, H-2', 3', 4', 3 a-CH), 5.26 (1H, d, J=4.4 Hz, OH), 5.60
(1H, d, J= 8 .1 HZ, H-5), 5.75 (1H, d, J= 6 . 8 Hz, H-l'), 7.67
(1H, d, J= 8 .1 Hz, H- 6 ), 7.82 (1H, t, J=5.1 Hz, e-NH of
Lys), 7.95 (1H, broad d, J=5.9 Hz, CONH), 8.49 (1H, d,
J=7.3 Hz, CONH). Elemental Analysis. Found: C, 51.63; H,
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7.50; N, 11.62%. Calculated for C 3 oH 5 oOioN 6 . 2.5 H 20 : C,
51.49; H, 7.92; N, 12.01% .

Leucvl-nikkomvcin Z (4^

Nikkomycin Z (double TFA salt)

(38 mg, 50 umol) and

Z-Leu-ONp (23.2 mg, 60 umol) were dissolved in a mixture of
DMF (0.5 mL) and H 20 (0.15 m L ) . NMM (17 mL, 150 umol) was
added and the mixture allowed to react, with stirring, at
room temperature, for 24 hr. After acidification with
acetic acid (50 uL), the solvents were evaporated in vacuo,
the residue treated with ether, filtered and subjected to
transfer hydrogenation for 2 hr as described above. After
filtration through celite, washing the filter with water,
evaporation and precipitation with ether, 35.4 mg of crude
material was obtained, which was purified by HPLC on a
semiprep Aquapore RP-18 column with 0.1% TFA/MeOH 95:5 as
eluant. Homogeneous 5 (26.1 mg) was obtained.
45%).

(Yield =

[a] D 25 = +17.0 (c=0.1, AcOH). Rf = 0.27 (1-butanol:

acetic acidswater, 4:1:2). NMR. s H D M S 0 " d 6
J= 6 .4 HZ, C H 3 - 3 " ) ,

0.66 (3H, d,

0.89 (6 H, m, C H 3 of Leu) , 1.45-1.70

(3H, m, p-CH 2 and T“CH of Leu), 3.8-4.2, 4.5-4.7 (H-27, 3',
4 7, 5', 2 " ,
H-4"),

a-CH of Leu, unassigned), 4.75 (1H, broad,

5.70 (1H, d, J=7 . 8 Hz, H-5) 5.81 (1H, d, J=5.4 Hz,

H-l7) , 7.2-7.4 (2H, m, H - 3 ' " ,
Hz, H- 6 ),

8

4 777), 7.49 (1H, d, J=7.8

.0-8.2 (4H, broad, N H 3+ and H- 6 '77), 8.43 (1H,
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d, J= 8 .3 Hz, CONH), 8.63 (1H, d, J=7.8 Hz, CONH), 9.95 (1H,
broad, ArOH), 11.42 (1H, s, NH-3). Elemental Analysis.
Found:

C, 34.70; H, 4.23; N, 7.45%. Calculated for

C 2 «H 3 6 0 h N 6 • 3.5 C F 3 C O 2 H •

8

H 20 : C, 34.41; H, 4.86; N,

7.30%.

Leucvl-nikkomycin X (3)

Nikkomycin X (double TFA salt)

(40 mg, 53 umol) was

processed as described above for nikkomycin Z, with the
exception that 1.2 equivalents of Boc-Leu-ONp were used as
the coupling reagent. Coupling time was 30 hr. Deprotection
was accomplished with TFA/CH 2 C 1 2 (50:50) in 0.5 hr. The
solvents were evaporated under vacuo, and the residue
precipitated with ether and filtered. Crude product (36.2
mg) was purified by HPLC using a 15 cm x 19 mm C-18 column,
with TFA 0.05% / MeOH 96:4 as the eluant. Homogeneous 3
(20.5 mg) was obtained after concentration and
freeze-drying (Overall yield = 39%).

[a] D 25 = +18.0 (c=0.1,

AcOH). Rf = 0.29 (1-butanol:acetic acid:water, 4:1:2). NMR.
5 HDMS°-d6

0>66

J=6>6 HZf CH - 3 " ) ,

0.89 (6 H, m,

C H 3 of Leu), 1.45-1.70 (3H, m, p-CH 2 and t“CH of Leu), 3.75
- 4.65 (H-2', 3', 4', 5', 2 " ,
4.76 (1H, broad, H - 4 " ) ,
7.2-7.4

5.47 (1H, d, J=4.3 Hz, H-l'),

(2H, m, H - 3 " - 4 " ) ,

broad m, N H 3+ and H- 6 " ) ,

a-CH of Leu, unassigned),

7.72 (1H, S, H-5),

8

.0-8.2 (4H,

8.46 (1H, d, J=9.0 Hz, CONH),
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8.64 (1H, d, J=9.5 Hz, CONH), 9.24 (1H,
s, NH-3). Elemental Analysis. Found:
8.84%. Calculated for C 2 6 H 3 6 0iiN6

S,

CHO), 11.2 (1H,

C, 38.96; H, 4.57; N,

• 3 C F 3 C 0 2H •

2.5 H 20 :

C, 38.60; H, 4.45; N, 8.44%.

Leucvl-oolvoxin B (5)

Polyoxin B (TFA salt)

(62 mg, 0.1 mmol) and Z-Leu-ONp

(46 mg, 0.12 mmol) were dissolved in a mixture of DMF (1
mL) and H 20 (0.3 m L ) . NMM (22.4 uL, 0.2 mmol) was added and
the mixture stirred at room temperature for 44 hr.

After

acidification with acetic acid (0.1 m L ) , the solvents were
evaporated in vacuo, and the residue treated with ether and
filtered. 40 mg of Z-Leu-polyoxin B (yield = 53%) was
obtained. Rf = 0.72 on silica thin layers with
n-BuOH/AcOH/H20 (1:1:1) as the eluant.

This product was subjected to transfer hydrogenation
in methanol (2 mL) with palladium black (s30 mg) and 90%
formic acid (0.2 mL) for 24 hr. The crude product was
purified on a C 18 reversed-phase column using 0.05%
TFA/MeOH (100:1) as eluant. The fractions containing pure 4
were pooled, evaporated under vacuum and freeze-dried. 7.2
mg of material, showing more than 92% purity by HPLC
analysis, was obtained. Other fractions containing 4 were
concentrated under vacuum and reinjected onto the 19 cm x
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150 mm C-18 column with 0.05% TFA/MeOH (10012) as the
eluant. 4.5 mg of 100% HPLC homogenous material was
obtained after concentration and freeze-drying.

(Overall

yield: 11%). [a] D 26 = +14.0 (c=0.1, AcOH). Rf = 0.22
(1-butanol:acetic acidrwater, 4:1:2). NMR. sHDMS0"d6

0.89

(6 H, d, J=5.4 Hz, C H 3 of Leu), 1.45-1.80 (3H, m, p-CH 2 and
T-CH of Leu), 3.6-4.3, 4.4-4.7 (m, unresolved, H-2', 3',
4', 3 " ,

4",

C H 2 “5 " ,

C H 2 0H, 3 a-CH), 5.81 and 5.82 (1H,

split d, J=5.9 Hz, H - l '),
(1H, s, H- 6 ),

8

6

.4-6 . 8

(2H, broad, OCONH2), 7.42

.0-8.2 (3H, m, N H 3+), 8.65 and 8.90 (1H,

split d, J=8.1 Hz, CONH), 8.74 (1H, d, J=7.8 Hz, CONH),
11.50

(1H, s, NH-3), 13.15 (1H, broad s, C 0 2 H ) . Elemental

Analysis. Found:

C, 34.60; H, 3.90; N, 8.46%. Calculated

for C 2 3 H 3 6 0 1 4 N 6 • 3.5 C F 3 C 0 2H • H 20 : C, 34.73; H, 4.03; N,

8 .10%.

L-4-Oxalvsvl-UPOC.

(Olv-UPOCl. (10)

N 2 ,N 6 -di-Benzoyloxycarbonyl-L-4-oxalysine was prepared
by standard procedures 2 0 from L-4-oxalysine, and
crystallized from ether.

(Rf = 0.52, C H 2 C l 2/MeOH 10:3.2).

It was converted into the p-nitrophenyl ester by coupling
to p-nitrophenol with dicyclohexylcarbodiimide in THF and
crystallizing from isopropanol. Yield: 50%. This product
was homogeneous on silica thin layers (Rf=0.76, C H 2 C l 2/MeOH
95:5). NMR.

8HCDC13

3.32-3.47 (2H, m, €-CH2), 3.53-3.66
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(2H, m,

8 -CH 2 ),

3.84 (1H, dd, J=9.3 Hz, 3.0 Hz, p-CH), 4.08

(1H, dd, J = 9 .3, 3.0 Hz, p-CH), 4.77 (1H, m, a-CH), 4.99
(1H, broad,

€-NH), 5.08 (2H, s, benzylic C H 2), 5.15 (2H, s,

benzylic C H 2), 5.79 (1H, d, J=7.2 Hz, a-NH), 7.2-7.4 (1 2 H,
m, phenyl), 8.17 (2H, d, J=8.5 Hz, meta of p-NO 2 -phenyl).
(a,e-dibenzyloxycarbonyl)-Oly-ONp (85.7 mg, 160 umol) was
coupled to UPOC.HC1 (46.9 mg, 145 umol) in DMSO (1.45 mL)
in the presence of DIEA (50.5 uL, 290 umol) at room
temperature for 25 hr. The reaction mixture was acidified
with acetic acid (300 uL) and the solvents evaporated in
vacuo to dryness.

The residue was suspended and triturated

in AcOH 1%, filtered, suspended and triturated in ether,
and filtered. This diprotected dipeptide was homogeneous on
silica gel thin layers (Rf=0.29, 1-butanol:acetic acid:
water, 4:1:2). It was suspended in MeOH (4 mL) and
subjected to transfer hydrogenation with palladium black
(«40 mg) and 90% formic acid (0.4 mL) with stirring at room
temperature overnight. The catalyst was removed by
filtration through Celite, the filtrate evaporated under
vacuo to dryness, and the residue suspended in E t 20,
triturated and filtered.

Yield 33.4 mg (45%). Rf=0.09

(1-butanol:acetic acid:water, 4:1:2). Due to the extremely
high hydrophilicity of this material, no satisfactory
reversed-phase HPLC analysis could be performed, but its
homogeneity was supported by TLC, NMR and elemental
analysis.

[a] D 25 = +25.8 (c=0.12, H 2 0 ) . NMR.

8HDMS°-d 6
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2.95 (2 H, m, €-CH2), 3.57 (in, p-CH2, t-CH2), 4.02-4.35 (m,
H-5', a-CH, H-2'-3'-4'), 5.62 (1H, d, J= 8 .0 HZ, H-5), 5.78
(1H, d, J= 6 . 6 Hz, H-l'), 7.76 (1H, d, J= 8 .0 Hz, H- 6 ), 8.01
(1H, d, J = 7 .7 Hz, CONH), 8.24 (2H, s, formate counterion).
Elemental analysis. Found: C , 38.64; H, 5.92; N, 13.25%.
Calculated for C 1 5 H 2 3 O 9 N 5 . 2 C H 20 2 • H 20 :

C, 38.71; H,

5.54; N, 13.28%.

meta-Fluorophenvlalanvl-UPOC f11)
Benzoyloxycarbonyl-(d ,l)-m-fluorophenylalanine was
prepared by standard procedures 2 0 from
(d,l)-m-fluorophenylalanine and crystallized from ether.
Yield, 81%,

(Rf=0.56, n-butanol:acetic acid:water, 4:1:2).

It was converted into the p-nitrophenyl ester by coupling
to p-nitrophenol with DCC in THF and crystallizing from
isopropanol. Yield 52%. NMR.

8 HDMSO_d6

3.0-3.3 (2H, m,

p-CH2), 4.61 (1H, m, a-CH), 5.05 (2H, s, benzylic C H 2),
7.03-7.43

(11H, m, phenyl), 8.14 (1H, d, J=7.7 Hz, OCONH),

8.32 (2H, d, J = 9 .0 Hz, raeta of p-NO 2 -phenyl).
(d , l )-Z-m-fluorophenylalanine-p-nitrophenylester was
coupled to UPOC.HC1 as described for compound 10.

The

protected dipeptide was homogeneous on silica gel thin
layers (Rf=0.46, 1-butanol:acetic acid:water, 4:1:2). It
was subjected to transfer hydrogenation as described above.
Yield 59 mg (55%). The two diastereomers were observed on
TLC (Rf=0.17 and 0.21, 1-butanol: acetic acid: water,
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4:1:2) and were separated by semipreparative HPLC. 37 mg of
the product were injected onto the Waters C i 8 column and
eluted with 0.025% TFA in H 2 0:acetonitrile, linear gradient
of 5% to 10% acetonitrile in 1 hr.

In this way, 18.5 mg of

one diastereomer (peak I) and 11.5 mg of the other (peak
II) were obtained.
Peak I:

[ oO

d

25

= +44.1 (c=0.17, H 2 0 ) . NMR.

6H D M S O "d 6

2.8-3.2 (m, P-CH ), 3.99 (1H, t, J=3.8 Hz, H-4'), 4.0-4.3
(3H, m, a-CH, H-2', H-3'), 4.62 (1H, m, H-5'), 5.35 (broad,
OH), 5.51 (1H, d, J=5.4 Hz, OH), 5.67 (1H, d, J=8.1 Hz,
H-5), 5.80 (1H, d, H = 5 .8 Hz, H-l'), 7.02-7.45 (4H, m,
phenyl), 7.53 (1H, d, J=8.1 Hz, H- 6 ), 8.2 (very broad s,
N H 3+), 8.96 (1H, d, J= 8 .1 Hz, CONH), 11.4 (1H, broad s,
NH-3). Elemental analysis.

Found:

C, 43.00; H, 4.08; N,

9.53%. Calculated for C i 9H 2 i0 8 N 4F • C 2 F 3 0 2H • H 20 :

C,

43.16; H, 4.14; N, 9.59%.
Peak II:
2.8-3.2

[a] D 25 = -28.6 (c=0.07, H 2 0 ) . NMR.

8

HD M S 0 _ d 6

(m, P-CH2), 3.9-4.0 (1H, m, H-4'), 4.0-4.3

(3H, m,

a-CH, H-2', H-3'), 4.53 (1H, m, H-5'), 5.63 (1H, d, J=8.3
Hz, H-5), 5.76 (1H, d, J=5.8 Hz, H-l'), 6.97-7.44 (4H, m,
phenyl), 7.61 (1H, d, J=8.3 Hz, H- 6 ), 8.83 (1H, broad d,
J = 7 .0 Hz, CONH), 11.38 (1H, broad s, NH-3). Elemental
analysis.

Found: C, 40.44; H, 3.94; N, 9.10%. Calculated

for C 1 9 H 2 i0 8N 4F • 1.3 C 2 F 3 0 2H . 2.2 H 20 :
4.20; N, 8.75%.

C, 40.52; H,
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N - ( 4-Methoxvfumarovl) -

l - 2

.3-diaminopropanovl-UPOC.

rFMDP-UPOC). (121

N 2 - (tert-Butoxycarbonyl)-N 3 -(4-methoxyfumaroyl) -

l - 2

,3-

-diaminopropanoic acid was converted into the p-nitrophenyl
ester by using dicyclohexylcarbodiimide in THF and
crystallizing from ethyl acetate:ether. Yield: 75%. This
product was homogeneous on silica thin layers using
C H 2 C l 2/MeOH (8:2, Rf=0.80) as eluant. NMR 5HDMSO“d6

1.41

(9H, s, tert-butyl), 3.68 (2H, m, p-CH2) , 3.73 (3H, S,
O C H 3), 4.40 (1H, m, a-CH), 6.63 (1H, d, J=15.4 Hz, C=CH),
7.02 (1H, d, J=15.4 HZ, C=CH), 7.41 (2H, d, J=8.9 Hz,
ortho-phenyl), 7.58 (1H, d, J=7.5 Hz, OCONH), 8.34 (2H, d,
J= 8 .9 Hz, meta-phenyl), 8.82 (1H, t, J=5.7 Hz, p-NH).
Boc-FMDP-ONp (104 mg, 238 umol) was coupled to UP0C*HC1 (70
mg, 216 umol) in DMSO (2.16 mL) with added DIEA (75.3 uL,
432 umol) by stirring at room temperature for 17 hr. The
solvent was evaporated in vacuo to dryness, and the residue
suspended and triturated in ether, and filtered.

(Rf=0.32,

l-butanol:acetic acid:water 4:1:2). The protecting group
was removed by treatment with 2 mL of 2N HCl/dioxane, and
93.1 mg of product were obtained (Rf=0.21, 1-butanol:acetic
acid:water, 4:1:2, yellow color with ninhydrin spray). 60
mg of this crude, product were purified by injection onto
the Aquapore RP-18 column in 10 mg shots (solvent: TFA
0.025%; flow rate, 4.50 mL/min). 12 mg of a s 98% pure
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fraction was obtained, as well as 26.5 mg of a s 95% pure
fraction. Overall yield (coupling-deprotectionpurification): 41%.
SH D M S 0 " d 6

[a]D25= +20.0 (c=0.11, H 2 0 ) . NMR.

3.55 (2H, m, P-CH2), 3.73 (3H, s, O C H 3), 3.94-

4.26 (4H, m, H-2'-3'-4' and a-CH), 4.68 (1H, dd, H-5'),
5.35 (1H, d, J = 5 .0 HZ, OH), 5.54 (1H, d, J=5.7 Hz, OH),
5.67 (1H, d, J= 8 .3 HZ, H-5), 5.78 (1H, d, J=6.0 Hz, H-l'),
6.61 (1H, d, J=15.6 HZ, C=CH), 6.98 (1H, d, J=15.6 H z ,
C=CH), 7.45 (1H, d, J=8.3 H z , H- 6 ), 8.24 (broad, N H 3+) ,
8.69 (1H, m, p-NH), 9.09 (1H, d, J=8.2 Hz, CONH), 11.44
(1H, s, NH-3) Elemental analysis.

Found:

C, 35.76; H,

4.00; N, 10.16%. Calculated for C i 8H 2 3 0iiN 5 •
. 2.6 H 20:

1.5 C 2 F 3 0 2H

C, 35,86; H, 4.26; N, 9.96%.

Biological Methods

Organisms: The following yeast strains were studied: c.
albicans H-317, a clinical isolate from the Center for

Disease Control, Atlanta, GA; c. albicans 124 and C.
albicans 124 NikR, nikkomycin sensitive and resistant

strains, respectively, from Dr. William Kingsbury, Smith,
Kline and French Laboratories, Philadelphia, PA.

Chitin Synthetase Assay

Total chitin synthetase activity obtained in a mixed
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membrane fraction from C. albicans H-317 was assayed in the
presence and absence of polyoxin compounds by measuring the
incorporation of N-acetylglucosamine into chitin.

The

detailed procedures have been previously reported27,28.

Peptidase Assay

The procedures used to prepare a cell extract of C.

a l b i c a n s H-317 in assays for hydrolysis of the antibiotics
were previously reported). To assay for hydrolysis, TLC as
well as HPLC were used. 0.5 mg of the antibiotic was
dissolved in 50 uL of H 2 0:DMSO (50:50) and mixed at 3 6 °C
with 200 uL of cell extract (3.75 mg protein/mL). The
mixture was incubated at 36 °C, and at 20 min intervals
small portions were withdrawn and directly chromatographed.
Nle-UPOC 9 was used as a control, and was completely
hydrolyzed after

1

hr under these conditions.

Transport Studies

The procedures and transport conditions to assay for
the uptake of labeled trimethionine and dileucine in the
presence of polyoxin compounds have been previously
described27,16. Cells of strain H-317 were harvested at
10 6 cells/mL by centrifugation after growth in yeast
nitrogen base with isoleucine (0.5%) as nitrogen source.

8

x
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After two washes with sterile distilled water, the cells
were resuspended in 2% glucose and warmed at 37 °C for 10
min. An equal volume of cells was

added to citric acid (10

mM)-KH 2 P 0 4 (lOmM) buffer at pH 3.5 with radioactive
trimethionine (2.9 x 10 -5 M, 1 pCi/pmol ) 29 or pH 5.5 buffer
with radioactive dileucine (5.6 x 10 ' 5 M, 44 pCi/pmol ) 3 0 to
a total volume of 1 mL. Analogs were added at 10-fold the
molar concentration of the transport substrates for
competition. At intervals of 0, 1, 2, 3, and 4 min, 180 pL
of the reaction mixtures were withdrawn and applied to
prewet filters (pore size 0.45 pm) and washed twice with
2mL of cold distilled water. The filters were placed in 5
mL of scintillation cocktail and counted.

The rate of

uptake was calculated as nanomoles of peptide taken
up/milligram of dry weight cells per minute.

Determination of MIC

The methods and procedures employed for the
determination of the MIC values in the presence of the
polyoxin analogs have been described previously except that
ammonium sulfate (0.5%) was used for most experiments as
the nitrogen source27,16. The MIC was recorded as the
lowest concentration of drug that resulted in 5%
morphologically aberrant cells as visualized by microscopy
after a 24-48 h incubation at 37 °C in yeast nitrogen base

81

(Difco Labs, Detroit, M I ) .
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Abbreviations used:

DMF, dimethylformamide; DMSO,

dimethylsulfoxide; DSS, sodium 3 - (trimethylsilyl)-1-propanesulfonate; FAB, fast atom bombardment; FMDP,
N 3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid; HOBt,
hydroxybenzotriazole; ID 50, concentration at which chitin
synthetase is inhibited by 50%; MIC, minimum inhibitory
concentration; lowest concentration that clearly inhibits
growth; Nle, norleucine; NMM, N-methylmorpholine;
(oct)Lys-, N-€-(octanoyl)-lysyl; Oly, L-4-oxalysine; TFA,
trifluoroacetic acid.

Table 7

Synthetic tripeptide chitin synthetase inhibitors

0
y— n»“
h 3n .—

•/

HO

OH

Chitin
Synthetase
Inhibition ” “ ““
(IDS0‘,ug/oL)
H-317

COMPOUNDS

1 Leu-(oct)Lys-UPOC

2

(oct )Lys-(oct )Lys-OPOC
0

3 Leu-Nikkonycin X

4

Leu-Nikkonycin Z

CHj(CH2)6CONH-(CHj)4-

O^H
0

CH3(CHa)6CONH-(CHj)4-

3

HN-Y
= 0
N
I
O

5

Leu-Polyoxin B

HO ^ N

S-CHjOH

0*N

124N5

% Transport
inhibition11
(Leu)z

(Het)3

50

> 666

> 666

> 666

-

0

32

80

> 666

> 666

> 666

-

60

56

(CH3)jCHCHj-

30

166

83

333

+

0

22

(CH3)jCHCHj-

100

> 666

666

> 666

+

0

28

(CHjJjCHCHj-

20

333

333

666

+

0

27

(CHJ)jCHCHj-

CH3(CHj)6CONH-(CH2)4-

CH
OH

HN

HH

124

Hydro'lysis'

OH

:h g

O^N
‘«r

HICb
(ug/aL)

ho ^

h

ch»

9«
OH

‘Concentration at which chitin synthetase is inhibited by 50%. bMiniaua inhibitory concentration; lowest concentration of drug that clearly inhibited
growth of strains H-317, 124 and 124N5 of C. albicans. c(+) conpound was hydrolyzed by C. albicans H-317 extract, (-) no hydrolysis by cell extract.
'Percent inhibition of transport of (Leu)z or (Met)3 into C. albicans H-317. A 10-fold aolar excess of analogue was used in coaparison to the transport
substrates (Leu)7 or (Het)3.
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Table 9

Effect of various toxic amino acids on growth of C. albicans
strains3
MIC (ug/mL)

Amino acid
Oxalysine
(d ,l )-m-F-phenylalanine
FMDPb

H-317
31

124
31

124N5
31

>1000

>1000

>1000

7.8

7.8

15.6

aC. albicans strains H-317, 124, and 124N5 were grown in the presence
of various amounts of toxic amino acid and their minimum inhibitory
concentration (MIC) determined. bFMDP is N 3-(4’
-methoxyfumaroyl)-L-2,3diaminopropanoic acid.
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Appendix A: Hydrolysis of nikkomvcin bv cell extracts from
C_. a l b i c a n s .

Polyoxin D has been shown to resist hydrolysis by
intracellular peptidases from c.

albicans

(61). This

resistance to peptidases is necessary for the fungicidal
action of the polyoxins, since the constituent amino acids
are not chitin synthetase inhibitors. Nikkomycins are more
toxic than the polyoxins and it is reasonable to expect
that they would also resist enzymatic hydrolysis. There is
no previous report in the literature about the stability of
nikkomycins toward hydrolysis by fungal peptidases and we
had to investigate this point. It has been mentioned at the
end of Chapter I that nikkomycins X and Z are slowly
degraded in a neutral aqueous solution at room temperature.

It is seen in Figures 5 and 6 that the negative slopes
for the HPLC areas of nikkomycin X versus time are very
similar when cell extracts are or are not present. The same
is seen for the positive slopes of the degradation
products. This indicates that nikkomycin X is not
hydrolyzed by cell extracts from C. albicans.

During the non-enzymatic hydrolysis, half of the
original nikkomycin is consumed in 44 hr., under the
conditions of the assay (see Figure 5).
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Figure 5

40

60

80 V

Plot of concentration of nikkomycin X vs time. Numbers
on vertical axis are areas of HPLC peaks. X, x: nik X
with and without C. albicans cell extract. A, a: degra
dation product(s) with and without cell extracts. 0.5 mg
of antibiotic was dissolved in 250 uL buffer tris.HCl
0.1 H, NaCl 0.1 M, pH 7.23 @ 20°C with or without cell
extract and incubated at 37°C. 10 uL samples were injec
ted onto an Aquapore spheri-5 RP18 column (22 cm x
4.6 mm). The eluant was H 20 with 0.1% TFA and with a
linear gradient of MeOH from 0 to 10% in 30 min. The flow
rate was 1.4 mL/min and the UV detector was set to 254 nm.
The cell extracts were described in the previous section.
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Chapter IV. Conformational studies on nikkomycin X.

Solution studies.

The conformational study of nikkomycin X in aqueous
solution is a first step toward understanding the molecular
interactions of this antibiotic with the proteins which
recognize it as a substrate (peptide permeases) or as an
inhibitor (chitin synthetase). Once these interactions are
understood, it should be possible to design a drug that
would be translocated more efficiently into the cytoplasm,
and/or that would be a better chitin synthetase inhibitor.

In 1984, Rathman et. a l . (50) presented conformational
parameters in DC1/D20 for the aminoacids nikkomycin C, [1(S'-amino-S'-deoxy-p-D-allofuranosyluronic acid)uracil],
and nikkomycin C x, [1-(5'-amino-5'-deoxy-p-D-allofuranosyl
uronic acid)uracil]. These two antibiotics are the carboxy
terminus aminoacids of nikkomycin X and nikkomycin Z
respectively (see Table 2, Chapter I). Using coupling
constants 3J(C-2,H-1'), they deduced an anti conformation
for both nucleosides, with an angle of the uracil ring
plane

x

= 32° or 88° for nikkomycin C, and an angle of the

imidazolinone ring plane

x

= 22° or 98° for nikkomycin C x .

They also calculated relative populations of rotamers of
the exocyclic C-4' C-5' bond using proton-proton and
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carbon-proton coupling constants. For both antibiotics the
trans (t) rotaxners were the most populated ones (70%).
Finally, using the coupling constants of the ribose ring
protons they calculated pseudorotational parameters and
relative populations of types N and S conformers. They
assumed a geometry for the S-type conformers identical to
the one found in the crystal (50).

As a preliminary experiment for the study of the
conformation of nikkomycin X in aqueous solution,

1H-nmr

spectra of dilute samples of nikkomycin X («2.5 mg/mL) were
run in water and different techniques for suppressing the
immense solvent peak were tried. A closed capillary with
D 20 was placed inside the nmr tube for signal lock. The top
spectrum in Figure 7 was obtained without suppression. The
presence of the water resonance introduced serious
distortions associated with the high dynamic range of the
spectrum, including inadequate analog-to-digital converter
resolution, and computer memory overflow. The solvent
resonance, with its first and higher order spinning
sidebands, obscures most of the spectrum and severely
distorts the baseline. The bottom spectrum (Figure 7) was
obtained by irradiating the sample with the 1331 sequence
proposed by Hore (82), which is designed to selectively
excite all the protons except those of the solvent. In this

a

D ,0

two

H-5
H*r 3*

tft

T J U t
• .a

Figure 7

7 .0

S .0

200 MHz 1H-nmr spectrum of nikkomycin X, obtained
a) in H 20; b) in D 20; c) in H 20 with the 1331
pulse sequence. Reference: internal DSS.

9 .0
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way it was possible to obtain a higher than 250-fold
suppression of the solvent signal and observe exchangeable
protons, such as the amide NH («8.95 ppm) and the
imidazolinone NH-3 (ell ppm). These latter resonances
cannot be seen in D 20 solution (Figure 7, middle spectrum).

Attempts were also made to suppress the water peak by
irradiating the sample with a selective low power
saturating pulse prior to pulsing and observation. This
procedure, although straightforward to implement, runs the
risk of saturation transfer by chemical exchange from the
solvent to the solute spins. Indeed, even though the
information that could be obtained in a run at pH 5.65 was
roughly the same as when using the 1331 sequence, the amide
NH and the imidazolinone NH-3 resonances did not show up
(data not shown). Therefore the saturating pulse technique

proved inferior to the 1331 sequence in this particular
case.

The problems associated with the 1331 pulse technique
were the following. First of all, the resonances within
s0.6 ppm from the water peak could not be detected. This
region includes both a-CHs and all the ribose ring protons
except H-l'. Secondly, due to the limited spectral region
that is excited, three independent runs were necessary in
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order to obtain a complete spectrum. Specifically, the
bottom spectrum in Figure 7 is a composite of three
separated spectra where the regions of interest were
selectively excited by using three different sets of delays
between pulses ( 0 . 7 ,

1 . 2 and 2.5 msec).

In the next section it will be shown how pH titration
studies yielded information on the conformation of

nikkomycin X in aqueous solution. Since the 1331 pulse
sequence allowed the monitoring of both exchangeable and
non-exchangeable protons, it was the method of choice for
carrying out those studies.
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Conformational studies of nikkomycin X in aqueous solution.
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Conform ational Studies of Nikkomycin X
in A queous Solution
ED U A RD O K R A M E R ," FRED N A ID E R ,'* a n d JEFFREY M . BECKER’
'D e p a rtm e n t o f Chemistry, College o f Staten Island, S taten Island, N ew York 10301, and
’ D ep artm ent o f M icrobiology, University of T ennessee, Knoxville, T en n essee 37916

SYNOPSIS
Nikkomycin X is a peptidyl-nucleoside antibiotic that inhibits chitin synthesis in fungi.
Information on its conformation in aqueous solution was obtained from p H titration studies
in which the n m r shifts of exchangeable and nonexchangeable protons were monitored.
These studies and nuclear Overhauser effects support an unfolded or conformationally
flexible structure for the antibiotic, and the syn and anti conformations of the nucleoside
moiety were found to coexist. T he conformation of the ribose ring was determined using a
two-state model; a slight shift from type N to type S conformers occurred as the p H was
raised from 1 to 6.

INTRODUCTION
Nikkomycin X (also called neopolyoxin A; Figure
1), a peptidyl nucleoside antibiotic produced by
Strep to m yces tendae, is a strong inhibitor of chitin
synthetase from pathogenic fungi.1"3 This antibiotic
is toxic to the zoopathogenic fungus C andida albicans
only at relatively high concentrations, a fact that is
very likely due to its poor binding and translocation
into the cell by permeases.4,3
Determination of the potential conformations
and flexibility of nikkomycin X in aqueous solution
is a first step toward understanding the molecular
interactions of this and other related antibiotics with
large membrane associated proteins such as peptide
permeases and chitin synthetase. Previous analysis6
of long-range coupling constants V (C -2, H -l') for
the isolated carboxy terminus amino acid of nik
komycin X [l-(5'-amino-5'-deoxy fi-D-allofuranosyluronic acid)-4-formyl-4-imidazoline-2-one] in
DC1/D20 indicated that the nucleoside moiety has
an a n ti conformation, with an angle of the imidazo
linone ring plane o f X = 22° or 98°. The relative
© 1990 John Wiley & Sons, Inc.
C C C 0006-3525/90/8/91297-10 104.00
Biopolymers, Vol. 29,1297-1306 (1990)
* To whom correspondence should be addressed.
1Submitted this work in partial fulfillment of requirements
for a Ph.D in Cbemistiy at the City University of New York.

populations of rotamers of the exocyclic C4'-C5'
bond, as well as N- and S-type ribose conformers in
DC1/D20 , were calculated using proton-proton and
carbon-proton coupling constants.6
Since C. albicans grows well at a pH of approxi
mately 4-4.5 while the cytoplasmic pH in yeast is
very close to neutrality,7 we decided to study the
conformation of nikkomycin X at different pH val
ues. We therefore measured lH*nmr chemical shifts
and coupling constants in the pH range from 1 to
6. These titrations were carried out on dilute aqueous
nikkomycin, using the 1331 pulse sequence proposed
by Hore8 to generate the nmr spectra. Under these
conditions the strong water resonance was barely
excited and we were able to gain access to infor
mation on exchangeable protons, such as the amide
and the imidazoline NH resonances, without the risk
of saturation transfer. Information on these ex
changeable protons would not be available from
samples run in D20 . We also explored the possible
existence of a folded conformation of nikkomycin
X by measuring nuclear Overhauser effects (NOEs)
upon irradiation o f the resolved proton signals.

MATERIALS AND METHODS
Nikkomycin X was purified as described previously9
and obtained as a double trifluoroacetate salt. All
nmr samples were 0.1 M in KCi in order to avoid a

Reprinted by permission of the publisher
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Figure 1 The p H titration shifts of some nikkomycin X resonances at 25°C. The as
signments are indicated on the right.

change in ionic strength upon addition o f the titrants
(0.1 N HC1 or 0.1 N N a O H ). T h e concentration o f
nikkom ycin X was & 2.5 m g /m L . Sodium 3-(trim ethylsiiyl)-l-propanesulfonate (D S S ) was used as
an internal reference, and a closed capillary con 
taining D 20 was placed inside th e nmr tube for signal
lock. T h e reference D S S has been shown to be e s
sentially independent o f pH when compared to ace
ton e in D 20 (p H 1 - 1 1 ) . , 0 Therefore no attem pt was
made to correct for possible pH -dependent shifts.
‘H -nm r spectra at 200 M H z were obtained on a
Bruker spectrom eter equipped w ith an A SPE C T
2000A com puter, a t 25 ± 1 °C. T h e temperature was
controlled w ith a Bruker variable tem pe;ature unit
( V T U ) by passing heated air through the probe. T he
V T U w as calibrated before each run w ith an e th 
ylen e glycol therm om eter. T h is consisted o f a closed
capillary containing ethylene glycol, inside a 5-m m
ninr tube w ith DM SO -d«. T h e separation in hertz
betw een th e m ethylene and hydroxyl proton reso
nan ces w as previously correlated w ith the tem per
ature by obtaining direct temperature measurem ents
w ith a therm ocouple at different V T U settings. W a
ter suppression w as achieved w ith a 1331 pulse se 
quence .8 T h e transm itter pulse w as attenuated (9
db ) and a n e t tip angle o f =; 45° w as obtained with

a total 1331 pulse w idth o f 24 ps. T h e delay between
pulses was set at 0.7, 1.2, and 2.5 m s, in order to
exam ine different regions of th e spectrum. In each
case, 2 0 0 transients were recorded and the relaxation
delay w as 8 . 0 s.
T h e pH readings were obtained w ith a Radiom e
ter pH m eter, model P H M 82, using a com bination
glass pH electrode (W ilm ad, Buena, N J ) specially
designed to fit in to a 5-m m nmr tube. Since th e so 
lutions were n ot buffered, th e p H was measured prior
to and after th e nmr runs, and the readings were
averaged. In virtually all cases the variation in the
pH w as less than 0.05 pH u n its. T h e titration curves
reflect p oin ts obtained by first adding base until the
pH rose to pH ~ 6 and additional p oin ts obtained
by back titrating w ith acid. Curve fitting of the t i 
tration data w as carried out w ith th e regression
an alysis routine o f th e Lab O ne N M R 1 software
from N ew M eth ods Research, Inc. (Syracuse, N Y ).
T h e iterative m ethod used is based on th e Levenberg-M arquardt algorithm . 11
Equilibrium N O Es were m easured at 200 M H z
on th e Bruker spectrom eter and a t 400 M H z on a
JE O L spectrom eter. N ikkom ycin concentrations
were 4 m g /m L at 200 M H z a nd 8.5 m g /m L at 400
M H z in D 20 containing 0.10 M KC1. M easured pD *s

C O N F O R M A T I O N A L STUDIES OF N I K K O M Y C I N X

(m eter readings uncorrected for the isotope effect
on the glass electrode) were 4.0 (a t 400 M H z) and
4.5 (a t 200 M H z ). A t th is latter p D * th e H -5 res
onance w as resolved from th e hydroxypyridine res
onances. Irradiation tim es o f 3.5 s (400 M H z) and
2.5 8 (200 M H z) were used, and all m easurem ents
were made at room temperature. In th e run at 200
M H z the follow ing precautions were taken in pre
paring the sample: D 20 low in param agnetic im 
purities (Aldrich, M ilwaukee, W I) (m inim um iso
topic purity 99.96 atom % D ) was used; the glassware
was washed with a solution o f E D T A in D 20 prior
to use, and the final solution was subjected to eight
freeze-pum p-thaw cycles at 0.5 mm. H g under dry
helium . T h e m agnitudes and number o f N O E s ob
served were basically equivalent for both sets o f e x 
periments. Spectral analysis by computer sim ulation
w as carried out in som e cases (see th e results and
discussion section) with PANIC (a LAOCOON type
program 12) on the A S P E C T computer.

T able I

Proton
NH-3
H-6
CONH
H-6"
H-3"-4"
H-5
H-l'
H-4'
H-5'1
H-3'1
H-2'1
H-2'1
H-4'1
H-3'
Me-3’

RESULTS AND DISCUSSION
T h e different protons in nikkom ycin X produce t i 
tration curves reflecting th e deprotonation o f acidic
groups. In th e sim plest case th e curveB are described
by the H enderson-H asselbach relationship:

pH = pK a + log —

(1)

wherein AH and A are concentrations o f protonated
and deprotonated species, respectively.
W ithin the fast exchange condition, the chem ical
shift 6 is linearly related to the fractional populations
o f species A and AH:

6=

A +A H

4a + A

AH
+A H

4ah

‘H-NM R T itration P aram eters o f N ikkom ycin X in HaO
*AH*
1 1 .0 0

9.28
9.28
8.247
7.933
7.675
5.654
5.49
4.751
4.621
4.521
4.42'
4.351
2.72
0.778

A5b
±0.02d
±0.01*
-0.61
-0.189
-0.520
+0.080
-0.030
±0.05'
nd
nd
nd
nd
nd
±0.02*

±o.oor

pKa'

«/<Hz)

_

__

—

2.95 ±0.05
4.341 ± 0.025
4.353 ± 0.020
2.82 ± 0.06 (2.90 ± 0.04)h
2.85 ±0.06
—

nd
nd
nd
nd
nd

—

7.0
nd’
nd
—

= 5.09 ±
2.3*
Jf f = 3.62 ±
J y = 5.45 ±
J y y = 5.33 ±
4.6
Jvr

—

—
—

—

7.0

0.05'
0.05'
0.05'
0.05'

*Calculated chemical shift in parts per million from internal DSS in the fully protonated nikkomycin,
or average 6 when the titration pattern was not simple or curve fitting was not attempted (see footnotes d
and e). For samples run in DjO, observed chemical shift (see footnote i).
bCalculated Ai “ - im). ‘H-nmr titration shiftin parts per million. Negative numbers indicste upfield
shifts upon deprotonation.
cCalculated pKa corresponds to microconstant pk,, within the assumptions referred to in the Appendix.
*The variation in i for NH-3 did not follow any discernible curve. It islikely that the true A5 is less than
0.04 ppm.
*No simple titration, or curve fitting not calculated. The chemical shiftvaried within the limits indicated
about average t.
'Not determined.
*Doublet broadened by “benzylic" long-range coupling to H-3”.
kValues in parentheses obtained when point at lowest p H isomitted from the correlation (see Figure 2
and text).
1Sample run in D sO at pD* 2.2.
iCoupling constant calculated through computer simulation for sample run in DjO at pD* 2.2.

(2)
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Figure 2 The p H titration shifts of H-T, H*5, and H-6". The dashed line on the plot
for H-5 is obtained when the point at lowest p H is omitted from the correlation.
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Figure 2. (Continued)

Thus, Eq. ( 1 ) can be written as
pH = pK a + iog -r— ^T
fiA - a

(3 )

or rearranged to
,

6kh + 5a10,pH pK,)

1+ io"’hpk,»

...

'’

Equation (4 ) w as used for nonlinear least-squares
curve fitting o f the titration data, treating the pK a
and the chem ical sh ifts o f th e fully protonated ( 6 Ah )
and fully deprotonated species (iA = 5AH + Ad) as
adjustable param eters. In th is way we were able to
determ ine pK a values to better than ± 0 . 1 pK a unit
and to te st th e fit o f the data to th e H en dersonH asselbach model. T h e titration curves are shown
in Figure 1, and b est-fit values for th e param eters
are given in Table 1 .
T h e am ide proton resonance show s an upheld t i
tration sh ift o f -0 .6 1 ppm. Intrinsic titration sh ifts
(sh ifts th a t arise from interaction w ith an ionizable
group m ediated only via covalent b o n d s) are always
to higher field upon deprotonation and have been
show n to be on the order o f —0.3 to - 0 .6 ppm for
th e am ide proton o f th e C -term inal am ino acid res

idue in som e short peptides . 13 In those studies the
pK a for th e titration curve w as identical to th e pKa
o f the a-carboxyl group determ ined by 13C-nm r.u
In th e case o f nikkom ycin X , w e found th at the
am ide proton titration data agrees w ell w ith a curve
generated by Eq. (4 ) ( Figure 1 ). T h e calculated pKa
for th e ionization o f th e carboxyl group o f nikko
mycin X is 2.95 ± 0.05. A s the pH is raised the amide
proton resonance o f nikkom ycin X starts to broaden
due to an increase o f the rate o f exchange w ith th e
solvent, catalyzed by O H - io n s .16,16 T h e coupling
con stan t for the doublet is no longer m easurable at
p H 5.15, and no attem p ts were made to run spectra
above pH 6 .
T h e protons o f th e pyridine ring show intrinsic
titration sh ifts due to deprotonation o f th e pyridinium ion. T h ese hydrogen atom s form an A B X system
and th e chem ical sh ift o f th e cen ter o f th e A B por
tio n — H -3 ” and H-4™— in addition to th e sh ift for
th e X part— H - 6 ™— are plotted in Figure 1 . From
both curves th e sam e pK a value, 4.35, is obtained
for th e pyridine nucleus (T ab le I ) .
B oth pK a values (carboxylic acid and pyndinium
io n ) are in excellen t agreem ent w ith previously re
ported p K as .2 T h e nearest additional ionizable group
( a - N H j ) h as a pK a = 7 .3 2 and therefore nik ko
m ycin X behaves a s a diprotic acid over th e pH range
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o f th is study. A s seen in Figure 1, deprotonation of
th e tw o acidic groups overlaps to a sm all exten t (th e
pyridinium ion begins to deprotonate before carboxylate formation is com plete). Equation (4 ) holds
exactly for monoprotic acids or for stepw ise depro
tonation o f polyprotic acids. N evertheless, it can be
used to a very good approxim ation for fittin g our
titration data for the follow ing reasons: (a ) T he
chem ical sh ifts o f th e resonances studied show only
one inflection point; they thus depend on th e exten t
o f protonation o f only one o f th e acidic groups, (b )
Since th e tw o acidic groups are far apart in the m ol
ecule, th e m icroscopic dissociation constan t for one
o f them will n o t appreciably change i f th e other
group is protonated or deprotonated ( see A ppendix).
T h e im idazolinone proton H -5 and th e ribose
proton H - l' show sm aller titration sh ifts o f + 0.08
and - 0 .0 3 respectively. Expanded titration curves
are shown in Figure 2. T he calculated pK a values
for th ese curves are in good agreem ent w ith the pKa
deduced from the amide titration ( Table I ), and thus
correspond to th e ionization o f the carboxyl group.
For H -5 the correlation (and also the match o f p K a s)
is im proved if the point at low est pH is om itted.
T h is point (w hich shows the greatest deviation from
the calculated curve) was obtained using a separate
sam ple o f nikkom ycin dissolved directly in 0.1 N
HC1 w ithout KC1 (see the materials and m ethods
section ). AH other points were obtained on th e same
nikkom ycin sam ple.

W e conclude, th en , that the CO NH , H -5 and Hsh ifts can be described by eq. ( 4 ) , with an inflec
tion a t the pK a o f the carboxylic acid. In the case
o f H -5 and H -l', th is im plies an intramolecular
through-space interaction betw een these protons
and th e carboxyl group. For direct interaction o f the
carboxyl group and H -5 to occur, the nucleoside
m oiety has to adopt a conformation in which the
im idazolinone ring is anti (Figure 3 ) . Furthermore,
th e signs o f th e H -5 and H - 1 ' titration sh ifts ( Table
1 ) can be rationalized on th e basis of repulsion be
tween the negative charge on th e carboxylate anion
and a electrons in th e C-H bonds . 17 In the geom et
rical arrangem ent expected for nikkom ycin in an
a n ti conform ation, these interactions will tend to
shield H - l ' and deshield H -5 from th e magnetic field.
T he possibility o f an indirect effect of the carboxyl
group titration on H -5 when the im idazolinone ring
is in the syn conform ation cannot be totally e x 
cluded. If the carboxyl group hydrogen bonds with
the heterocyclic oxygen (oxygen on C -2), titration
would affect th is interaction and m ight result in a
change in chem ical sh ift o f th e H -5 resonance. N ev 
ertheless, we view th is possibility as unlikely since
both H - 6 and N H -3 exhibited significantly smaller
changes than H -5 upon titration o f the carboxyl
group (T ab le I ) . W e conclude that the titration be
havior o f H -5 supports th e presence o f an anti con 
formation for th e heterocyclic ring. In any event the
titration experim ent provides evidence th a t th e car1'

CHO
CHO

C-5'

HO

OH
ANTI

C-51

HO

OH
SYN

3

N-l

Type N

Type S

P - 0°

P - 180°

F igu re 3

Conformations of imidazolinone nucleosides.
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boxyl group is situated above th e plane o f th e ribose
ring and close to th e im idazolinone heterocycle.
T h e im idazolinone N H -3 proton could only be
observed betw een pH 2.0 and 3.5 as a broad reso
nance a t 11.0 ppm. A t other p H values, a fast rate
o f exchange w ith th e solvent, catalyzed eith er by H +
(low p H values) or by O H ' (high pH v a lu e s), pre
vented its detection. For other resonances observed,
th e titration sh ifts were much sm aller (T able I ) and
did not show a sim ple sigm oidal pattern.
T he only ribose ring proton th at could be observed
during th e titration experim ents in H 20 was H -l'.
R esonances falling w ithin 1 ppm o f the water peak
(oth er ribose ring protons, H -5', H-2", and at high
pH values H -4 ') could not be detected u sin g H ore’s
sequence. W hen nikkom ycin w as run in D 20 at pD *
2 .2 , all th e ribose protons were resolved at 200 M Hz.
Computer sim ulation o f th e ribose ring portion o f
th e spectrum at pD * 2.2 gave som e o f the parameters
shown in T able I.
The conformation o f ribose rings can be described
unequivocally by the puckering am plitude (r a ) and
the phase angle o f pseudorotation ( P ) . I0 In nucleo
sides and nucleotides in solution, th e furanose ring
is engaged in a conformational equilibrium described
by N - and S -typ e conform ers (Figure 3 ) . , 0 A n exact
treatm ent o f a tw o-state model is n ot possible, since
only three observables are available from th e nmr
experim ent (Jyy,Jyz,and Jyv)whereas the con
form ation in solution is fully described by five pa
ram eters ( P Nt t n , P s , rg, and th e m ole fraction o f
N -conform er X n ), resulting in an underdetermined
system . N evertheless, an approxim ate approach is
possible , 19 in which Jyyis assum ed to have th e same
value for th e tw o "pure” conformers and th e sum
J i ‘y + J 3<f is assum ed to be practically independent
o f th e m agnitude o f th e equilibrium constan t. A
classical K arplus-type two-param eter equation 20 is
used for th e calculations. T h e above assum ptions,
as well a s th e derivation o f th e K arplus parameters,
rely on geom etrical considerations in the solid state
for an exten sive set o f nucleosides and nucleotides.
In th is w ay a fairly accurate value o f X n can be ob 
tained, a s w ell as estim ates o f th e rem aining param 
eters. (For possible alternative treatm ents, see Refs.
2 1 and 2 2 ).
According to th e above treatm ent, w e obtained
at pD * 2.2, t n = 35°, P N = 16°. rs = 37.5°, Pg
= 165.5°, and X n *= 0.50. Therefore there is n o par
ticular preference for eith er th e N - or S -typ e conformer at pH 2 .2 , and th e values o f th e phase angles
fall w ithin th e preferred pseudorotational regions
for ribose nu cleosides . 10
Inspection o f th e H - l' resonance throughout the

titration experim ent reveals th a t J i <y gradually in 
creases with the pH , from a value o f 4.3 H z a t pH
1 .0 , to 5.9 H z at pH 5.85 (Figure 4 ) . H owever, the
J i *2 ' values are based on a first-order analysis o f the
spectra, since the other pentoBe resonances are bur
ied under th e water peak. T o analyze the putative
effects o f higher order sp in -sp in interactions on
J-i'T, we sim ulated nm r spectra run in D 20 at pD *
- 2.2 ( 200 M H z, see above and th e m aterials m eth 
ods se c tio n ) and a t pD * = 4.0 (400 M H z ), and used
these to calculate coupling con stan ts for th e ribose
protons. A t pD * = 4.5 and 200 M H z th e spectrum
o f nikkom ycin was com plicated by overlap of H -3'
and H -5' and second-order coupling interactions.
T h e higher m agnetic field (400 M H z) led to sign if
icant spectral sim plification. T he coupling constants
at pD * = 2.2 are listed in T able I. A t pD * = 4.0
th ey were J y y = 5.75 ± 0.08 H z, J 2-y = 5.34 ± 0.08
H z, J 3’4‘ = 4.65 ± 0.08 H z, and J y y = 4.04 ± 0.08
H z. As seen in the p lo t in Figure 4, th e calculated
J i >2 'S are slightly higher th an th e observed on es at
both low (2 .2 ) and high (4 .0 ) pD * values. T h is su p
ports our conclusion th a t th e true coupling constan t
does increase w ith the pH . Our interpretation, based
on th e approxim ation 19 X n =: 1 - 0.10 X J ,- y , is
th a t the variation shown corresponds to a sh ift o f
th e conform ational equilibrium from X n = 0 . 6 to
X n = 0.4 as th e p H increases from 1 to 6 .
T h a t J t increases from 3.62 ± 0.05 H z at pD *
2.2 to 4.04 ± 0.08 H z at p D * 4.0 indicates th at the
sh ift o f the equilibrium from N - to S-typ e conform 
ers is accom panied by rotational changes along the
C 4’-C 5’ bond. Previous studies in both solution and
the solid state have also found a correlation betw een
the nature o f th e ribose ring puckering and the con 
form ation o f th e C H 2OH group in pyrim idine nu 
cleosides . 19,23
T h e coupling constan t «/nh-«>ch did n ot vary from
pH 1 to 5 (T ab le I ) , indicating th a t there are no
significant conform ational changes along th e N -aC
bond. Its value o f 7.0 H z is close to th e m ean value
for N H -a C H coupling con stan ts in p ep tid es 24 and
suggests conform ational freedom for th is particular
bond (s e e b e lo w ).
N O E s are displayed in Figure 5. D ue to th e size
o f th e m olecule, th e contribution to th e relaxation
processes from th e double- and zero-quantum p ath
w ays are approxim ately equal in magnitude, and the
N O E s detected are therefore sm all and positive. B e 
cause th e em ail size o f th e N O E s m akes tw o-d im en
sion al N O E experim ents (N O E S Y ) impractical,
one-dim ensional experim ents were run, using long
irradiation tim es (2 .5 -3 .5 s ) in order to obtain m ax
im um N O E s. Q uantitative determ inations o f d is
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5.00-

4.00-1
2.00

0.00

6.00

pH
Figure 4 Plot of«/,<2>vs pH, at 25°C. Open circles represent data obtained by first-order
analysis from spectra run in H 2O. Solid circles represent points obtained by computer
simulation of spectra run in D aO.
tances by measuring initial slopes o f the tim e d e
velopm ent o f N O E s were not attem pted due to the
signal-to-noise problem at Bhort tim es. T here were
no through-space interactions betw een hydrogen

atom s o f th e tw o am ino acids, although N O E s be
tw een hydrogen atom s w ithin a given am ino acid
were observed. W e conclude th a t nikkom ycin X is
conform ationally flexible in water and th a t there is

OH
F igu re 6 NOE measurements on nikkomycin X ( 8 . 6 m g/m L) in DjO, at 400 MHz. The
solution was 0.10 M in KC1 and the pD* was 4.0. Arrows go from irradiated to enhanced
protons. Numbers are NOEb percent relative to the intensity of the saturated peak in the
difference spectrum.
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n o detectable stabilized folded conform ation. T h e
N O E s observed betw een H -5 and H -2', and H -5 and
H -3', support th e existen ce o f an a n ti conform ation
in th e nucleoside m oiety. Surprisingly, N O E s were
measured betw een H -5 and H - l' (Figure 5 ) . Cal
culations carried out on a closely related uracil n u 
cleoside have dem onstrated M th a t a m easureable
N O E betw een H -5 (H - 6 in uracil) and H - l' is n ot
expected for th e an ti conformer, and th u s our result
show s th a t th e syn conform ation is significantly
populated as well. T h e existence o f th e syn confor
m ation is in contrast to previous reports 6 th a t have
indicated th e conform ation o f the carboxy term inus
am ino acid o f nikkom ycin X in aqueous solution to
be anti. N evertheless, th ese latter stu dies 6 were
based on coupling constan ts and th e calculated con 
formation m ight be a weighted average o f popula
tions w ith very different angles o f th e im idazolinone
ring plane (X ).

AH; X H

,

H,AH; :

1

A XH
AH,

H .A X H
'

H.AH;

:

A X H
;

H,A

For a unique resonance ( a resonance with a chemical
sh ift dependent on th e degree o f protonation o f only
one o f th e acidic groups, say group i ) , th e observed
chem ical sh ift [com pare to Eq. ( 2 ) ] is
(A 2)
w here
and
are th e fractional protonation and
deprotonation o f group i, and 6^, and
the chemical
sh ifts o f species w ith group i fully protonated and
fully deprotonated for that particular unique reso
nance .86 Since (/tp + /td ) = l,E q . (A 2) can be written

5 5i,p _ /i.d

CONCLUSION

^i,d

T he following conformational changes were detected
during th e titration o f nikkom ycin X from pH 1 to
6 : a sh ift from N -typ e ribose to S-typ e o f approxi
m ately 2 0 % upon deprotonation and rotational
changes along th e C 4-C 5' bond. T h e titration data
supports th e existen ce o f a conformer w ith th e carboxylic group above th e ribose plane and th e im id
azolinone ring in an a n ti position, whereas there is
evidence from the N O E experim ents th at both the
anti and syn conformations are populated. N o N O Es
could be detected between protons o f th e tw o am ino
acids, and th is supports an unfolded or conformationally flexible structure for nikkom ycin X in
aqueous solution. T hese studies define the solution
conform ation o f nikkom ycin and provide a basis for
the exam ination o f th is m olecule bound to chitin
synthetase or th e peptide perm ease o f C. albicans.

APPENDIX
A diprotic acid ionizes according to th e follow ing
schem e:
H ,A H , ^ AH;

Ol *
"Jl H*.
H ,A

^

A

where k,-, kj,
and %■,• are the m icroscopic acid d is
sociation constan ts, and th e subscripts i and j in 
dicate th e protons on acidic groups i and j . K T he
m icroconstants are defined as

(A l)

—i

(A 3 )

fi, p

Therefore,
6

- 6^

A + AH;

d - « ~ H,AH; + H,A

(A 4)

Su bstitu tin g Eqs. ( A l ) in to Eq. (A 4 ) and taking
logarithm s, gives

pH = pk, + log

(H

(A 5)

(*♦*)
W hen kjj a: kj, th e last term vanish es and Eq.
(A 5 ) is formally analogous to Eq. ( 3 ) . Since
= kjkji, th e condition
a kj is equivalent to k, a A,,
and m eans th a t an acidic group i will dissociate with
th e sam e dissociation m icroconstant w hether the
acidic group j is protonated or not. T h at is a rea
sonable assum ption if groups i and j are far away
from each other in th e molecule and cannot interact.
N otice also th a t th e pK a being m easured w ith the
m odel used in th is study [Eq. ( 4 ) ] corresponds to
the m icroconstant pk,.
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Appendix B; Conformation of the ribose ring of nikkomycin
X.

As Altona et al. have shown (83), the conformation of
ribose rings can be described unequivocally by the
puckering amplitude (xm) (or maximum angle of torsion) and
the phase angle of pseudorotation (P). According to their
treatment, the endocyclic torsion angles about the bonds
C(l')-C(2'), C(2')-(3'),
0(4/)-C(l/),denoted x l f

(3')-C(4'), C(4')-0(4'), and
t 2,

x3,

x4,

and x 0 respectively,

are related to xm and P by the pseudorotation equations
(84):

tl = ^mCOS(P - 144°)

x 2 = xmcosP

t3 = xmcos(P + 144°)

x 4 = xmCOS(P + 288°)

x0 =

+ 72°)

As the molecule completes a full pseudorotational cycle, P
goes from 0° to 360° and the dihedral angle x 2 passes
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through the values Tm , 0°, -xm , 0°, and tm again. The
torsion angle x3 moves in the same way, but with a phase
shift of + 144°, x4 with a phase shift of + 288°, and so
on.

In cyclopentane the phase angle P rotates without
significant change in potential energy. However, in
ribonucleosides, the presence of endocyclic and exocyclic
substituents gives rise to an energy barrier that opposes
free pseudorotation. The authors (84) called type N
conformers those with conformations occupying the northern
half of the pseudorotational circle (P = 0 ± 90°), and type
S conformers the ones that occupy the southern half of the
pseudorotational circle (P = 180 ± 90°). Based on X-ray
data for 60 nucleosides, they showed that p-purine and
p-pyrimidine ribosides prefer two narrow pseudorotational
ranges, each occupying less than 10% of all the possible
values of P (0 to 360°). Thus there is a type N potential
energy well for p-pyrimidine sugars with values of P
ranging from 2 to 25°, and a type S energy well with P of
161 to 175°. Although in the solid state either the N or
the S type conformers are found, in solution both
conformers are assumed to be present in dynamic
equilibrium. The observed 1H-nmr parameters in solution can
be fully explained by this two-state dynamic conformational
equilibrium model (83).
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Figure 8

Two ribose ring conformers of nikkomycin X in
aqueous solution. At pD* 2.2, the population of
each conformer is 50%.

The following parameters were deduced, for nikkomycin X
from proton-proton coupling data in D 20 solution at pD* 2.2
(see previous section):
tN= 35° ;

P N= 16° ; x s= 37.5° ; P s= 165.5° ; X N= 0.50

The two conformers in equilibrium are shown in Figure 8
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Based on the observed change of J i > 2> with the pH, it
was also shown in the previous section that the
conformational equilibrium shifts from X Ns 0.6 to X N« 0.4
as the pH increases from 1 to 6. This change is accompanied
by rotational changes along the C4'-C5' bond. It was
necessary to prove that the change in J i ■2 > was not due to
high order spin-spin interactions, and spectra run at pD* =
2.2 and pD* = 4 . 0 were simulated using PANIC (a LAOCOON
type program (85)) on an ASPECT 2000A computer (IBM). The
simulated spectra are shown in Figures 9 and 10.

W(l’)=5.641
W(2')=4.52A
H (3')=4.617
H(A•)=4.353
W (5’)=4.746

J1(2,=5.09+0.05

J 2 ,3 ,=5.33+0.05

J3 ,5 ,=-.02+0.05

Jl t3,=-.12+0.05

J2 ,A ,=-.12±0.05

J V 5 ,= 3 .6 1 + 0 .0 5

J11A,=0.03+0.05

J2 ,5 ,=0.01+0.05

Jr 5 ,=0.01±0.05

J3 ,a ,=5.A5+0.05

JUV.
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Ribose region of nikkomycin X. a) 200 MHz^H-nmr spectrum in D 20, pD*-2.2
(DSS internal reference), b) A sine bell multiplication and then zero filling
was applied to FID of spectrum (a) before FT in order to enhance the resolution,
c) Simulated spectrum. Calculated parameters are shown in upper panel,
W: chemical shifts in ppm, J in Hz.

W(l'>=2270.67
W(2'>=1810.58
W(3'>=1844.25
W(4'>=1755.78
W(5’>=1856.59
1 i 2 , = 5 . 7 5 ± 0 . 0 8

j

J1'3'="-06±0-08
J,,, =0.00±0.08
H-2'

H-3

H-2

j 1 i5,=o .o o ±o .o 8

J2'3’=5*34±0*08
4.0

J2.4,=--04±0*08

IS

H-5’*H-3' H-2' H-2"

i

J2'5’='*01±0*08
j

3 , 4 i = 4 . 6 5 ± 0 . 0 8

J3-5-='*02±0-08

• V 5 . ^ - 04±0*08
Figure 10

Ill

Ribose region of nikkomycin X. a) 400 MHz-1H-nmr spectrum in D 20, pD*-4.0
(DSS internal reference), b) A sine bell multiplication and then zero filling
was applied to FID of spectrum (a) before FT in order to enhance the resolution,
c) Simulated spectrum. Linewidth: 4.7 Hz (lorentzian). Calculated parameters
for this spectrum are shown at right, d) Sine bell multiplication and zero
filling were applied to simulated FID and then FT in order to simulate spectrum (b).
W (chemical shifts) and J in Hz. Horizontal axis corresponds to spectrum
(b) only. The ribose protons are indicated above the resonances.
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Transferred nuclear Overhauser effect.

The nuclear Overhauser effect (nOe) is a change in the
intensity of an nmr signal when the transitions of another
one are perturbed. The perturbation of interest is the
saturation of the particular nmr resonance. tii(s) is the
nOe at nucleus i when nucleus s is saturated, and occurs
due to cross relaxation (simultaneous transitions of two
spins) between nuclei. For a two-spin system relaxing via
dipolar coupling,
W

„i(. )
*

h
ou

-

—

V

^

i

2V + V2+ vo

where W 2 and W 0 are the rate constants for the double and
zero quantum transitions respectively, and Wi* is the rate
constant for the single quantum transition of nucleus i.
The strength of the dipolar interaction depends on the
internuclear distance. The numerator in the above equation
is the net cross relaxation of nuclei i and s
ois

■

w2

-

Wo

and the denominator is the total relaxation for nucleus i
Pi

a 2 W ! 1 + W2 + W0

If we have an inhibitor or small ligand, I,
interacting with an enzyme E, generally a protein of much
higher molecular weight,

it is possible that information relative to the cross
relaxation between two protons in I can be transferred from
the bound (IE) to the free state by chemical exchange. In
such case, irradiation of free I protons will result in
negative nOes in other free ligand protons, yielding
information about the proximity in space of nuclei in the
bound ligand (8 6 ). The use of the transferred nOe (trnOe)
does not require that the proton resonances of the protein
(or eventually the resonances of the bound ligand) be
resolved, extending its usefulness to the study of the very
largest systems (8 6 ).

A theoretical study of the dependency of the observed
trnOe on the relevant parameters has been carried out by
Clore e t a l .

(8 6 ). The parameters are: the rate constants

of chemical exchange, the expected nOes in the absence of
chemical exchange, the relative concentration of free
ligand to protein, the total spin-lattice relaxation rates
of the free and bound ligand resonances, and the molecular
weight of the protein. It is shown that in general, in the
slow chemical exchange limit on the spin-lattice relaxation
time scale of the free ligand (ki[E] + k_i < pif)/ attempts
to obtain structural information on the bound ligand by
measuring trnOes will be fruitless (except in special
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cases). Conversely, in the fast chemical exchange limit
(ki[E] + k_i > 10piF), trnOes can be used for obtaining
information on the bound state, provided a negative trnOe
is observed. Thus, for large proteins it is feasible to use
large excess of ligand and still obtain substantial
negative nOes and therefore useful conformational
information. Structural information of a quantitative
nature can be obtained from the trnOes by measuring their
initial build-up rates (87). Attempts to observe trnOes on
nikkomycin X in the presence of yeast membranes containing
active enzymes are described in the next section.
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Studies in the presence of active enzymes.

An understanding of how nikkomycins interact with
chitin synthetase and peptide permeases may lead to the
rational design of analogs with improved biological
properties (for instance increased inhibitor activity, or
increased permeability). The trnOe method has been used
recently to determine the conformation of various
enzyme-bound ligands (88,89) and agonists bound to
receptors (90). it may be possible, in principle, to
isolate chitin synthetase from c. albicans and carry out
trnOe measurements on its inhibitors. Pure chitin
synthetase in its active form has been isolated in an
ingenious way (co-precipitation with its product) from
another yeast, Saccharomyces cerevisiae

(13).

In order to investigate the feasibility of trnOe
experiments with pure c.

albicans enzymes, nOe measurements

on nikkomycin X in the presence of c. albicans membrane
fractions containing activated chitin synthetase (the same
membrane preparations used for the chitin synthetase
inhibition assays described in Chapter III) were performed.
Those preliminary experiments are described here.

EXPERIMENTAL PROCEDURES
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Mixed membrane fractions from various strains of
Candida albicans and from Sc hi zosaccharomyces pombe were

obtained in the same way as described for chitin synthetase
assays (see Chapter III, third section), with slight
modifications. Phosphate buffer in D 20 (99.996 % D,
Aldrich, Milwaukee, WI) was used in order to avoid
interferences in the nmr spectra. The following reagents
(at the specified concentrations) were present in the
enzyme preparation during the measurement of activity as
well as during the nmr experiments: K 2H P 0 4 , 30 to 60 mM;
EDTA, 0.06 mM; DTE, 0.16 mM; MgCl 2 , 6.2 mM; GlcNAc, 3.2
mM. For the nmr runs, the above reagents had been
previously freeze-dried twice from deuterium oxide in order
to replace the exchangeable protons. The pD* of the buffer
was adjusted to a value of 6.45 with DC1/D 2 0. The buffer
was microfiltered (0.4 urn) before use. In contrast to
enzyme preparations used previously for chitin synthetase
assays (see Chapter III), the ones studied here lacked ATP.
Chitin synthetase was activated with trypsin (0.04 mg/mL)
at 3 7 °C for 10 min, and then STI (0.06 mg/mL) was added.
These two soluble proteins were eliminated from the sample
by centrifuging at 20,000 rpm (4°C) 50 minutes and
replacing the buffer three times.

Lipid vesicles and lamellae were prepared by
suspending L-a-dipalmitoylphosphatidylcholine, chain
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deuterated (DPPC-d 6 2 • obtained from Cambridge Isotope
Laboratories, Woburn, Massachusetts) in phosphate buffer
(pD* 6.45 ) in a glass vial. A few small glass beads were
added and the suspension was vortexed for approximately one
minute. In order to prepare the vesicles, the sample was
transferred to a polypropylene vial and sonicated with a
Heat Systems W-380 Sonicator, according to the procedure of
Barrow et al.

(91). The water bath temperature was

maintained 10°C above the lipid phase transition
temperature (Tcss 41 °C) and sonication was continued up to
the point where the sample was almost clear. This required
less than an hour. The sample was then centrifuged for 15
minutes at

10,000

rpm in a microcentrifuge in order to

remove large and multilamellar vesicles, and was stored at
room temperature. The vesicle diameters were around 1500 A,
(p/7

2

=0.3), as determined by guasielastic light scattering

measurements using a Lexel Model 65 Argon-Ion Laser and
Langley Ford Model 1096 correlator.

Nmr experiments were performed at 200 MHz on a Bruker
spectrometer equipped with an Aspect 2000A computer. All
experiments were run at 300°K. NOes were measured by using
the following pulse sequence:

[RD-preirradiate(t,ci)

-observation pulse]8n for a list of frequencies w. RD, the
relaxation delay, was set to 7.0 sec; t, the duration of
the selective proton preirradiation, was varied from 0.50
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to 3.0 sec for different samples. The duration of the
observation pulse was adjusted for a tip angle of 90°. The
nOes were observed by substraction of a control FID
(obtained by off-resonance preirradiation) from the
experimental FID, multiplication of the difference FID by a
decaying exponential, and then Fourier transformation. The
magnitudes of the nOes were determined by peak height
measurements.

RESULTS AND DISCUSSION

When a 1H-nmr spectrum of a membrane fraction from
Candida albicans H-317

(16 mg protein/mL) containing active

chitin synthetase was run at 200 MHz, only a few broad
peaks were seen (Figure 11, trace b ) . Methyl groups and
other resonances were observed at high fields, whereas no
resonances were seen in the region from 5.5 to 11 ppm. When
nikkomycin X was added (8 mg/mL) most of the antibiotic
resonances, although broadened, could be observed (see
trace c ) . When a nikkomycin resonance, such as H-5, was
irradiated, negative nOes were observed (trace e ) . This is
*

in sharp contrast to nOes observed in the absence of the
enzyme-containing membranes, which were positive (see
previous section, and trace d ) . The negative nOes strongly
suggest that it is the enzyme-bound antibiotic which was
being "observed". However it is possible that changes in

* W *—y**
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1H-nmr spectra in D 20 of (a) Nikkomycin X, and (b) membrane fractions from Candida
albicans H-317 containing chitin synthetase; (c) Nikkomycin X plus the membrane
fractions; (d) NOe difference spectrum, same conditions as in (a), H-5 irradiated
(3 sec); (e) NOe difference spectrum, same conditions as in (c), H-5 irradiated
(500 msec). This figure appears in reference [92]).
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the solution viscosity were responsible for the change in
the sign of the nOes. Furthermore, it is also conceivable
that nikkomycin binds non-specifically to lipids or to
membrane proteins unrelated to chitin synthetase.

An ideal control experiment would necessitate
membranes from a strain of C. a l b i c a n s unable to synthesize
chitin. Since such a hypothetical strain is not viable, we
ran control experiments which consisted of measuring nOes
for nikkomycin in the presence of DPPC vesicles (16 mg/mL),
DPPC lamellae (16 mg/mL), or DPPC vesicles plus BSA (16
mg/mL of each). These lipids and protein mimic the cellular
components found in the membrane fractions of C. a l b i c a n s ,
probably generating a sample of comparable viscosity. In
all the control experiments the signs of the nOes were
identical to those obtained for free nikkomycin in
solution. These results are displayed in Table 10 (three
last columns), and support the conclusion that the negative
nOes observed in the presence of membrane fractions provide
conformational information on nikkomycin bound to chitin
synthetase.

It is possible that the above membrane fractions from
c, a l b i c a n s contain peptide permeases, and that these
proteins are still operative. In that case, they would
interact with nikkomycin and possibly yield negative nOes.
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none

H-317

124

124N5

S, pombe

DPPC
16 mg/mL
vesicles

0

31

62

62

62

25

50

50

16

90

88

160

0

16

0

0.95
15.2

0.25
22.5

0.25

0
0

0
0

0
0

0
0

8.0

8.0

8.0

26.2

7.8

8.0

8.0

8.2

4.4

4.1

4.6

4.8

4.6

2.9

4.3

2.5

0.600

3.0

3.0

Membranes

Buffer (mM)

Protein
(mg/mL) 0
Activity
(nmol/mg.mln] 0
(nmol/mL.min] 0
Nikkomycin
(mg/mL) 3.9
4.5

pD*

irradiation
2.50
time (sec)
irrad. enhanc.
CHO
H-5
+5.8
H-l*
H-6'" Py-4-3 n.d.
He-3"
H-5

CHO
+8.8
H-l'
+7.8
H-6'”
Me-3”

Py-4-3 CHO
n.d
H-6” '
H-l’
H-4”
H-3”
Me-3”

22.0

0.600

0.500

0.600

-8.4

-3.2

n.d.

0

-7.0
-6.9

-5.23
-7

-8.7
-3.8

n.d. -17.8
-6.3
-4.5
-3.5

positive
positive

n.d

n.d

n.d.

0

-2.2
-4.1
0
-1.5
■1.27 -3.7
0
-2.7
-1.7 -5.7

n.d.

-6.3

-5.1 -12.5
-2.4
n.d. n.d. -3.7
-2.3

positive f4.S +1.9

n.d.

n.d.

+5.8

negative

0

-7.8 n.d. ■11.0
-6.8
-1.4
-2.1
-4.3(7)

positive

H-3"

Me-3”
H-6'”
H-5
Py-4-3
H-4”
H-2”

0

n.d.

0

n.d. n.d. -25

n.d.

H-4’

Table 10

positive HI. 5 +2.8
positive +6.8 +2.6

n.d.

n.d.

positive

n.d.

+small

n.d.

-10
-6.2(7)

-20
-25
-25

H-3”
+small
CHO
H-6” '
H-5
Py-4-3
H-4”
H-2”
H-l'
H-l'
n.d.
H-5
H-l'

n.d.

-1.6

H-5
CHO
H-6'”
Py-3-4
H-4”

H-2'

3.0 0.500

positive

H-l’

He-3”

DPPC/BSA DPPC
16 mg/mL 16 mg/mL
vesicles lamellae

+8.4

negative

0

-3.4 n.d.

0
0
0
0
0

-2.1

0

-4.2
-2.6
-3.9
-2.1
-6.8
-6.2
-4.2(7)
-2.1

0

positive

+3.6

negative
negative

n.d.

n.d. n.d.

n.d.

n.d.

n.d.

n.d.

negative

n.d.

n.d. n.d.

n.d.

n.d.

n.d.

n.d.

Results of nOe experiments at 200 MHz on nikkomycin X in the
presence of yeast membranes or lipid vesicles. Solvent: buffer
phosphate in D 20. Temperature: 300°K. The magnitudes of the
nOes were determined by peak height measurements.
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NOe experiments in the presence of membranes from c.
albicans 124N5, a nikkomycin resistant mutant lacking a

dipeptide transport system were run. Those membranes are
not expected to have permeases able to interact with
nikkomycin. Membranes from the corresponding wild strain,
C.

albicans 124, were used as control.

Conversely, membrane

fractions from Schizosaccharomyces p o m b e , a yeast believed
to lack chitin synthetase, were used in parallel nOe
experiments. The results of all these experiments are
summarized in Table 10, and the nOe experiments with

s,

pombe membranes are shown in Figure 12.

The nOes in the presence of the nikkomycin resistant
mutant were negative, suggesting an interaction with chitin
synthetase. It was observed in this nmr run that the
H-3'''-4'" signal did split ca. 0.3 ppm, whereas the
H-6'"

signal was split 0.18 ppm (data not shown). When the

amount of nikkomycin was increased more than 3-fold, no
significant change in the magnitude of nOes was detected
(Table 10), but the split signals collapsed into the
expected pattern. At this point we are unable to give a
satisfactory explanation for the splitting of the pyridine
signals.

In the experiment with

s.

pombe membranes, negative

nOes were observed. Further biological tests showed that

A w ^ i '
V-25

|S f A v y A ^ W * * ^
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^
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1H-nmr spectra in D 20 of (a) Membrane fractions from Schizosaccharomyces pombe; (b) plus
nikkomycin X. (c) to (i) NOe difference spectra with various resonances irradiated. (For
experimental conditions, see Table 7). Magnitudes of nOes are indicated next to peaks.
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Figure 12

/A.
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this yeast's growth is inhibited at very high
concentrations of nikkomycin and it is therefore possible
that chitin synthetases are present in the membranes. In
addition to the nOes seen with other yeast membranes, an
extra set of small negative nOes was observed (Table 10 and
Figure 12). Many of those nOes, if they are primary nOes,
could indicate folding of nikkomycin. However, some degree
of spin diffusion seems to have occurred in this particular
experiment. Thus, it is very likely that the nOe from CHO
to H-l' was mediated by H-5, since the spatial relationship
between H-l' and CHO would preclude direct dipolar
interaction. The appearance of spin diffusion in this
experiment could be due to the higher concentration of the
membranes (Table 10), or possibly to the different sizes of
the cellular components.

CONCLUSION

The above experiments are preliminary and they raise
more questions than they answer. We cannot at this point
distinguish clearly between a fast chemical equilibrium or
a viscosity effect as the cause for the negative nOes
observed in the presence of membranes. The positive nOes in
the experiments with lipids suggest the chemical
equilibrium hypothesis to be the correct one, but this
cannot be conclusive. We think that this question can be
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addressed by using a viscosity probe, a small molecule
which should not interact with the membranes and on which
nOes can be measured. If positive nOes are observed in the
presence of membranes, the viscosity effect can be ruled
out as a cause for the negative nOes in nikkomycin. Amino
acids from the d -series would be suitable candidates for
these experiments since they are not expected to interact
with the membranes.

If transferred nOes are being measured, it will be
necessary to get an estimate of the exchange rate, in order
to know if quantitative structural data can be extracted
from those measurements. On the other hand it is important
to determine whether small nOes that could indicate
folding, such as some of the ones observed with S. pombe
membranes, are primary or due to spin diffusion. This can
be done by measuring nOe build-ups (87), preferably at
higher magnetic fields.
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Summary and perspectives

This thesis has described a combination of synthetic
and spectroscopic approaches to design improved inhibitors
against C. albicans. A novel mode of chromatography was
devised and used successfully for the separation and
purification of nikkomycins X and Z. The conditions for the
coupling of amino acids in the synthesis of nikkomycin and
polyoxin analogs were optimized. Some of the synthetic
analogs behaved as prodrugs but had low toxicity against C.
a l b i c a n s . Although the drug design strategies described

deserve further exploration, it was found that the
structural specificity for peptide transport in this yeast
is more complex than previously thought and the
permeability of new antibiotics cannot be predicted with a
reasonable degree of certainty.

The spectroscopic studies showed nikkomycin X to be a
very flexible molecule in aqueous solution and defined the
configuration of the ribose ring and the relative spatial
orientation of the imidazolinone heterocycle. Attempts to
measure trnOes for this antibiotic in the presence of yeast
membranes containing chitin synthetase resulted in data
that was very difficult to interpret due to the complexity
of the system and to the absence of a good control. It
would be of great interest to run nOe experiments on
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nikkomycins in the presence of purified chitin synthetase
and of purified peptide permease. Such experiments should
shed important structural information on the interaction of
chitin synthetase inhibitors with critical components of
the candidal cell membrane.
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